List of cancers available within this report
The list of cancers available in this report can be broken into 4 different types. These are, the core list of cancers generally reported on within the report, cancer by subsite, blood cancer by histology and selected other cancers by histology.
Core list of cancers
The core list of cancers available within the majority of CdiA reports are provided in the table below. On occasion and for various reasons, some cancers may not be available for some reports.
| Cancer group/site | ICD-10 code/s |
|---|---|
| Lip cancer | C00 |
| Tongue cancer | C01–C02 |
| Mouth cancer | C03–C06 |
| Parotid gland cancer | C07 |
| Submandibular gland cancer | C08.0 |
| Sublingual gland cancer | C08.1 |
| Cancer overlapping and unspecified sites in major salivary glands | C08.8–C08.9 |
| Cancer of the major salivary glands | C07–C08 |
| Oropharyngeal cancer | C09–C10 |
| Oral cancer | C00–C10 |
| Nasopharyngeal cancer | C11 |
| Hypopharyngeal cancer | C12–C13 |
| Cancer of other and ill-defined sites in the lip, oral cavity and pharynx | C14 |
| Head and neck cancer (including lip) | C00–C14, C30–C32 |
| Head and neck cancer (excluding lip) | C01–C14, C30–C32 |
| Oesophageal cancer | C15 |
| Stomach cancer | C16 |
| Small intestine cancer | C17 |
| Appendiceal cancer | C18.0 |
| Colon cancer | C18 |
| Rectosigmoid junction cancer | C19 |
| Rectal cancer (excluding rectosigmoid junction) | C20 |
| Rectal cancer (including rectosigmoid junction) | C19–C20 |
| Colorectal cancer | C18–C20 (NMD mortality data includes C26.0) |
| Anal cancer | C21 |
| Liver cancer | C22 |
| Gallbladder cancer | C23 |
| Extrahepatic bile duct cancer | C24.0 |
| Ampullary cancer | C24.1 |
| Cancer of overlapping and unspecified sites in biliary tract | C24.8–C24.9 |
| Gallbladder and extrahepatic bile duct cancer | C23–C24 |
| Pancreatic cancer | C25 |
| Cancer of other and ill-defined digestive organs | C26 (NMD mortality data excludes C26.0) |
| Nasal cavity cancer | C30.0 |
| Middle ear cancer | C30.1 |
| Sinuses cancer | C31 |
| Laryngeal cancer | C32 |
| Lung cancer | C33–C34 |
| Cancer of other thoracic and respiratory organs | C37–C39 |
| Bone cancer | C40–C41 (ACD data includes selected histologies) |
| Melanoma of the skin | C43 |
| Non-melanoma skin cancer | C44 (ACD data excludes basal and squamous cell carcinomas of the skin. These are the most common types of non-melanoma skin cancer and accordingly ACD based statistics for this cancer are described within this report as 'Non-melanoma skin cancer (rare types)'. The NMD includes basal and squamous cell carcinomas of the skin and is described within this report as 'Non-melanoma skin cancer (all types)'. |
| Mesothelioma | C45 |
| Kaposi sarcoma | C46 |
| Cancer of peripheral nerves and autonomic nervous system | C47 |
| Peritoneal cancer | C48 |
| Cancer of connective, subcutaneous and other soft tissues | C49 |
| Breast cancer | C50 |
| Vulvar cancer | C51 |
| Vaginal cancer | C52 |
| Cervical cancer | C53 |
| Endometrial cancer | C54.1 |
| Uterine cancer | C54–C55 |
| Ovarian cancer | C56 |
| Ovarian cancer and serous carcinomas of the fallopian tube | C56 (all histologies) and C57.0, C57.8 (with histologies 8441, 8460, 8461) |
| Cancer of other female genital organs | C57 |
| Cancer of other female genital organs excluding serous carcinomas of the fallopian tube | C57 excluding C57.0, C57.8 (with histologies 8441, 8460, 8461) |
| Placenta cancer | C58 |
| Gynaecological cancers | C51–C58 |
| Penile cancer | C60 |
| Prostate cancer | C61 |
| Testicular cancer | C62 |
| Cancer of other male genital organs | C63 |
| Kidney cancer | C64 |
| Renal pelvis cancer | C65 |
| Ureteral cancer | C66 |
| Bladder cancer | C67 |
| Urethral cancer | C68.0 |
| Cancer of overlapping and unspecified sites in urinary tract | C68.8–C68.9 |
| Eye cancer | C69 |
| Other central nervous system cancers | C70, C72, C75.1–C75.3 |
| Brain cancer | C71 |
| Brain and other central nervous system cancers | C70–C72, C75.1–C75.3 |
| Thyroid cancer | C73 |
| Cancer of other endocrine glands | C74–C75 (excluding C75.1–C75.3) |
| Cancer of other and ill-defined sites | C76 |
| Cancer of unknown primary site | C80 (NMD mortality data includes C77–C79, C97) |
| Hodgkin lymphoma | C81 |
| Non-Hodgkin lymphoma | C82–C86 |
| Lymphoma | C81–C86 |
| Immunoproliferative cancers | C88 |
| Multiple myeloma | C90.0 |
| Other plasma cell cancers | C90.1–C90.9 |
| Acute lymphoblastic leukaemia | C91.0 |
| Chronic lymphocytic leukaemia | C91.1 |
| Other and unspecified lymphoid leukaemia | C91.2–C91.9, C94.7 |
| Acute myeloid leukaemia | C92.0, C92.3–C92.8, C93.0, C94.0, C94.2, C94.4–C94.5 |
| Chronic myeloid leukaemia (CML) | C92.1 |
| Other and unspecified myeloid leukaemia | C92.2, C92.9, C93.2, C93.7, C93.9, C94.6 |
| Chronic myelomonocytic leukaemia (including juvenile) | C93.1, C93.3 |
| Myeloproliferative neoplasms (excluding CML) | C94.1, D45, D47.1, D47.3–D47.5 (NMD mortality data excludes C94.1) |
| Myeloproliferative neoplasms | C92.1,C94.1, D45, D47.1, D47.3–D47.5 (NMD mortality data excludes C94.1) |
| Other and unspecified leukaemias | C95 |
| Leukaemia | C91–C95 (NMD mortality data excludes C94.1) |
| Other blood cancers | C94.3, C96 |
| Myelodysplastic syndromes | D46 |
| All blood cancers combined | C81–C96, D45–D46, D47.1, D47.3–D47.5 (NMD mortality data excludes C94.1) |
| All cancers combined | C00–C96, D45–D46, D47.1, D47.3–D47.5 (NMD mortality data includes C97) |
Please note there are no deaths reported for C94.1 within the NMD. For simplicity, when ICD-10 coding for myeloproliferative neoplasms (excluding CML), leukaemia and all blood cancers combined is mentioned elsewhere in the report, the ACD ICD-10 coding alone may be cited.
| Cancer group | Histology codes |
|---|---|
| Neuroendocrine tumours | Histology including 8013, 8040-8045, 8150-8156, 8158, 8240-8249, 8345-8347, 8680-8683, 8690-8693, 8700, 9091 and also topography C73 with a histology of 8510 |
| Soft tissue sarcoma | Histology 8800-8936, 8990-8992, 9040-9045, 9120-9262, 9540-9582 for all topography codes except C40–C41 Histology 8936, 9140 for all topography codes Histology 9045 for all topography codes except C30, C32.3, C33, C34.0, C40–C41 |
| All sarcomas combined | All sarcomas combined is the aggregate of bone cancer and soft tissue sarcoma |
Note: Please refer to Cancer data commentary no. 7 'Updating sarcoma reporting' for more information on the coding of all sarcomas combined and bone cancer from the Australian Cancer Database.
Cancer list by subsite
The following cancers have incidence data available within the cancer by subsite data visualisation. Subsite refers to the 4-character and sometimes 3-character ICD-10 codes for the selected cancers. Survival data are available only where there are sufficient cases to derive a sufficiently reliable survival rate.
| Cancer | Cancer subsite |
|---|---|
| Anal cancer | anal cancer (C21) cancer of the anus, unspecified (C21.0) cancer of the anal canal (C21.1) cancer of the cloacogenic zone (C21.2) cancer of overlapping lesion of rectum, anus and anal canal (C21.8) |
| Bladder cancer | bladder cancer (C67) cancer of the trigone of bladder (C67.0) cancer of the dome of bladder (C67.1) cancer of the lateral wall of bladder (C67.2) cancer of the anterior wall of bladder (C67.3) cancer of the posterior wall of bladder (C67.4) cancer of the bladder neck (C67.5) cancer of the ureteric orifice (C67.6) cancer of the urachus (C67.7) cancer of overlapping lesion of bladder and bladder, unspecified (C67.8–C67.9) |
| Bone cancer | bone cancer ((C40–C41) and selected histologies) cancer of the bone and articular cartilage of limbs (C40) cancer of the scapula and long bones of upper limb (C40.0) cancer of the short bones of upper limb (C40.1) cancer of the long bones of lower limb (C40.2) cancer of the short bones of lower limb (C40.3) cancer of overlapping lesion of bone and articular cartilage of limbs and bone and articular cartilage of limb, unspecified (C40.8–C40.9) cancer of the bone and articular cartilage of other and unspecified sites (C41) cancer of the bones of skull and face (C41.0) cancer of the mandible (C41.1) cancer of the vertebral column (C41.2) cancer of the ribs, sternum and clavicle (C41.3) cancer of the pelvic bones, sacrum and coccyx (C41.4) cancer of overlapping lesion of bone and articular cartilage and bone and articular cartilage, unspecified (C41.8–C41.9) bone cancer (selected histologies in sites other than C40–C41)bone cancer (selected histologies in sites other than C40–C41) |
| Brain and other central nervous system (cancer of the) | cancer of the brain and other central nervous system (C70–C72, C75.1–C75.3) cancer of the meninges (C70) cancer of the cerebral meninges (C70.0) cancer of the spinal meninges (C70.1) cancer of the meninges, unspecified (C70.9) cancer of the brain (C71) cancer of the cerebrum, except lobes and ventricles (C71.0) cancer of the frontal lobe (C71.1) cancer of the temporal lobe (C71.2) cancer of the parietal lobe (C71.3) cancer of the occipital lobe (C71.4) cancer of the cerebral ventricle (C71.5) cancer of the cerebellum (C71.6) cancer of the brain stem (C71.7) cancer of overlapping lesion of brain and brain, unspecified (C71.8–C71.9) cancer of the spinal cord, cranial nerves and other parts of central nervous system (C72) cancer of the spinal cord (C72.0) cancer of the cauda equina (C72.1) cancer of the olfactory nerve (C72.2) cancer of the optic nerve (C72.3) cancer of the acoustic nerve (C72.4) cancer of other and unspecified cranial nerves (C72.5) cancer of overlapping lesion of brain and other parts of central nervous system and central nervous system, unspecified (C72.8–C72.9) cancer of the pituitary gland (C75.1) cancer of the pineal gland (C75.3) |
| Brain cancer | brain cancer (C71) cancer of the cerebrum, except lobes and ventricles (C71.0) cancer of the frontal lobe (C71.1) cancer of the temporal lobe (C71.2) cancer of the parietal lobe (C71.3) cancer of the occipital lobe (C71.4) cancer of the cerebral ventricle (C71.5) cancer of the cerebellum (C71.6) cancer of the brain stem (C71.7) cancer of overlapping lesion of brain and brain, unspecified (C71.8–C71.9) |
| Breast cancer | breast cancer (C50) cancer of the nipple and areola (C50.0) cancer of the central portion of breast (C50.1) cancer of the upper-inner quadrant of breast (C50.2) cancer of the lower-inner quadrant of breast (C50.3) cancer of the upper-outer quadrant of breast (C50.4) cancer of the lower-outer quadrant of breast (C50.5) cancer of the axillary tail of breast (C50.6) cancer of overlapping lesion of breast and breast, unspecified (C50.8–C50.9) |
| Cervical cancer | cervical cancer (C53) cancer of the endocervix (C53.0) cancer of the exocervix (C53.1) cancer of overlapping lesion of cervix uteri and cervix uteri, unspecified (C53.8–C53.9) |
| Colon cancer | colon cancer (C18) cancer of the caecum (C18.0) cancer of the appendix (C18.1) cancer of the ascending colon (C18.2) cancer of the hepatic flexure (C18.3) cancer of the transverse colon (C18.4) cancer of the splenic flexure (C18.5) cancer of the descending colon (C18.6) cancer of the sigmoid colon (C18.7) cancer of overlapping lesion of colon and colon, part unspecified (C18.8–C18.9) |
| Colorectal cancer | colorectal cancer (C18–C20) cancer of the colon (C18) cancer of the caecum (C18.0) cancer of the appendix (C18.1) cancer of the ascending colon (C18.2) cancer of the hepatic flexure (C18.3) cancer of the transverse colon (C18.4) cancer of the splenic flexure (C18.5) cancer of the descending colon (C18.6) cancer of the sigmoid colon (C18.7) cancer of overlapping lesion of colon and colon, part unspecified (C18.8–C18.9) cancer of the rectosigmoid junction (C19) cancer of the rectum (C20) |
| Connective, subcutaneous and other soft tissues (cancer of) | cancer of connective, subcutaneous and other soft tissues (C49) cancer of connective and soft tissue of head, face and neck (C49.0) cancer of connective and soft tissue of upper limb, including shoulder (C49.1) cancer of connective and soft tissue of lower limb, including hip (C49.2) cancer of connective and soft tissue of thorax (C49.3) cancer of connective and soft tissue of abdomen (C49.4) cancer of connective and soft tissue of pelvis (C49.5) cancer of connective and soft tissue of trunk, unspecified (C49.6) cancer of overlapping lesion of connective and soft tissue and connective and soft tissue, unspecified (C49.8–C49.9) |
| Eye cancer | eye cancer (C69) cancer of the conjunctiva (C69.0) cancer of the cornea (C69.1) cancer of the retina (C69.2) cancer of the choroid (C69.3) cancer of the ciliary body (C69.4) cancer of the lacrimal gland and duct (C69.5) cancer of the orbit (C69.6) cancer of overlapping lesion of eye and adnexa and eye, unspecified (C69.8–C69.9) |
| Gallbladder and extrahepatic bile ducts cancer | gallbladder and extrahepatic bile ducts cancer (C23–C24) cancer of the gallbladder (C23) cancer of other and unspecified parts of biliary tract (C24) cancer of the extrahepatic bile duct (C24.0) cancer of the ampulla of Vater (C24.1) cancer of overlapping lesion of biliary tract and biliary tract, unspecified (C24.8–C24.9) |
| Gynaecological cancers | gynaecological cancers (C51–C58) cancer of the vulva (C51) cancer of the labium majus (C51.0) cancer of the labium minus (C51.1) cancer of the clitoris (C51.2) cancer of overlapping lesion of vulva and vulva, unspecified (C51.8–C51.9) cancer of the vagina (C52) cancer of the cervix uteri (C53) cancer of the endocervix (C53.0) cancer of the exocervix (C53.1) cancer of overlapping lesion of cervix uteri and cervix uteri, unspecified (C53.8–C53.9) cancer of the corpus uteri (C54) cancer of the isthmus uteri (C54.0) cancer of the endometrium (C54.1) cancer of the myometrium (C54.2) cancer of the fundus uteri (C54.3) cancer of overlapping lesion of corpus uteri and corpus uteri, unspecified (C54.8–C54.9) cancer of the uterus, part unspecified (C55) cancer of the ovary (C56) placenta cancer (C58) ovarian cancer and serous carcinomas of the fallopian tube (C56 (all histologies) and C57.0, C57.8 (with histologies 8441, 8460, 8461)) cancer of the fallopian tube (C57.0 with selected histologies) cancer of overlapping lesion of female genital organs (C57.8 with selected histologies) cancer of other female genital organs excluding serous carcinomas of the fallopian tube (C57 excluding C57.0, C57.8 (with histologies 8441, 8460, 8461)) cancer of the fallopian tube (C57.0 excluding selected histologies) cancer of the broad ligament (C57.1) cancer of the parametrium (C57.3) cancer of the uterine adnexa, unspecified (C57.4) cancer of other specified female genital organs (C57.7) cancer of overlapping lesion of female genital organs and female genital organ, unspecified (C57.8–C57.9, excluding selected histologies in C57.8) |
| Head and neck cancer (including lip) | head and neck cancer (including lip) (C00–C14, C30–C32) cancer of the lip (C00) cancer of the external upper lip (C00.0) cancer of the external lower lip (C00.1) cancer of the external lip, unspecified (C00.2) cancer of the upper lip, inner aspect (C00.3) cancer of the lower lip, inner aspect (C00.4) cancer of the lip, unspecified, inner aspect (C00.5) cancer of the commissure of lip (C00.6) cancer of overlapping lesion of lip and lip, unspecified (C00.8–C00.9) cancer of the base of tongue (C01) cancer of other and unspecified parts of tongue (C02) cancer of the dorsal surface of tongue (C02.0) cancer of the border of tongue (C02.1) cancer of the ventral surface of tongue (C02.2) cancer of the anterior two-thirds of tongue, part unspecified (C02.3) cancer of the lingual tonsil (C02.4) cancer of overlapping lesion of tongue and tongue unspecified (C02.8–C02.9) cancer of the gum (C03) cancer of the upper gum (C03.0) cancer of the lower gum (C03.1) cancer of the gum, unspecified (C03.9) cancer of the floor of mouth (C04) cancer of the anterior floor of mouth (C04.0) cancer of the lateral floor of mouth (C04.1) cancer of overlapping lesion of floor of mouth and floor of mouth, unspecified (C04.8–C04.9) cancer of the palate (C05) cancer of the hard palate (C05.0) cancer of the soft palate (C05.1) cancer of the uvula (C05.2) cancer of overlapping lesion of palate and palate, unspecified (C05.8–C05.9) cancer of the other and unspecified parts of mouth (C06) cancer of the cheek mucosa (C06.0) cancer of the vestibule of mouth (C06.1) cancer of the retromolar area (C06.2) cancer of overlapping lesion of other and unspecified parts of mouth and mouth, unspecified (C06.8–C06.9) cancer of the parotid gland (C07) cancer of other and unspecified major salivary glands (C08) cancer of the submandibular gland (C08.0) cancer of the sublingual gland (C08.1) cancer of overlapping lesion of major salivary glands and major salivary gland, unspecified (C08.8–C08.9) cancer of the tonsils (C09) cancer of the tonsillar fossa (C09.0) cancer of the tonsillar pillar (anterior)(posterior) (C09.1) cancer of overlapping lesion of tonsil and tonsil, unspecified (C09.8–C09.9) cancer of the oropharynx (C10) cancer of the vallecula (C10.0) cancer of the anterior surface of epiglottis (C10.1) cancer of the lateral wall of oropharynx (C10.2) cancer of the posterior wall of oropharynx (C10.3) cancer of the branchial cleft (C10.4) cancer of overlapping lesion of oropharynx and oropharynx, unspecified (C10.8–C10.9) cancer of the nasopharynx (C11) cancer of the superior wall of nasopharynx (C11.0) cancer of the posterior wall of nasopharynx (C11.1) cancer of the lateral wall of nasopharynx (C11.2) cancer of the anterior wall of nasopharynx (C11.3) cancer of overlapping lesion of nasopharynx and nasopharynx, unspecified (C11.8–C11.9) cancer of the pyriform sinus (C12) cancer of the hypopharynx (C13) cancer of the postcricoid region (C13.0) cancer of the aryepiglottic fold, hypopharyngeal aspect (C13.1) cancer of the posterior wall of hypopharynx (C13.2) cancer of overlapping lesion of hypopharynx and hyphopharynx, unspecified (C13.8–C13.9) cancer of other and ill-defined sites in the lip, oral cavity and pharynx (C14) cancer of the pharynx, unspecified (C14.0) cancer of overlapping lesion of lip, oral cavity and pharynx (C14.8) cancer of the nasal cavity and middle ear (C30) cancer of the nasal cavity (C30.0) cancer of the middle ear (C30.1) cancer of the accessory sinuses (C31) cancer of the maxillary sinus (C31.0) cancer of the ethmoidal sinus (C31.1) cancer of the frontal sinus (C31.2) cancer of the sphenoidal sinus (C31.3) cancer of overlapping lesion of accessory sinuses and accessory sinus, unspecified (C31.8–C31.9) cancer of the larynx (C32) cancer of the glottis (C32.0) cancer of the supraglottis (C32.1) cancer of the subglottis (C32.2) cancer of the laryngeal cartilage (C32.3) cancer of overlapping lesion of larynx and larynx, unspecified (C32.8–C32.9) |
| Hypopharyngeal cancer | hypopharyngeal cancer (C12–C13) cancer of the pyriform sinus (C12) cancer of the hypopharynx (C13) cancer of the postcricoid region (C13.0) cancer of the aryepiglottic fold, hypopharyngeal aspect (C13.1) cancer of the posterior wall of hypopharynx (C13.2) cancer of overlapping lesion of hypopharynx and hyphopharynx, unspecified (C13.8–C13.9) |
| Kaposi sarcoma | Kaposi sarcoma (C46) Kaposi sarcoma of the skin (C46.0) Kaposi sarcoma of soft tissue (C46.1) Kaposi sarcoma of the palate (C46.2) Kaposi sarcoma of the lymph nodes (C46.3) Kaposi sarcoma of other sites (C46.7) Kaposi sarcoma of multiple organs and Kaposi sarcoma, unspecified (C46.8–C46.9) |
| Laryngeal cancer | laryngeal cancer (C32) cancer of the glottis (C32.0) cancer of the supraglottis (C32.1) cancer of the subglottis (C32.2) cancer of the laryngeal cartilage (C32.3) cancer of overlapping lesion of larynx and larynx, unspecified (C32.8–C32.9) |
| Lip cancer | lip cancer (C00) cancer of the external upper lip (C00.0) cancer of the external lower lip (C00.1) cancer of the external lip, unspecified (C00.2) cancer of the upper lip, inner aspect (C00.3) cancer of the lower lip, inner aspect (C00.4) cancer of the lip, unspecified, inner aspect (C00.5) cancer of the commissure of lip (C00.6) cancer of overlapping lesion of lip and lip, unspecified (C00.8–C00.9) |
| Liver cancer | liver cancer (C22) liver cell carcinoma (C22.0) intrahepatic bile duct carcinoma (C22.1) hepatoblastoma (C22.2) angiosarcoma of the liver (C22.3) other sarcomas of the liver (C22.4) other specified carcinomas of the liver (C22.7) cancer of the liver, unspecified (C22.9) |
| Lung cancer | lung cancer (C33–C34) cancer of the trachea (C33) cancer of the bronchus and lung (C34) cancer of the main bronchus (C34.0) cancer of the upper lobe, bronchus or lung (C34.1) cancer of the middle lobe, bronchus or lung (C34.2) cancer of the lower lobe, bronchus or lung (C34.3) cancer of overlapping lesion of bronchus and lung and bronchus or lung, unspecified (C34.8–C34.9) |
| Major salivary glands (cancer of the) | cancer of the major salivary glands (C07–C08) cancer of the parotid gland (C07) cancer of other and unspecified major salivary glands (C08) cancer of the submandibular gland (C08.0) cancer of the sublingual gland (C08.1) cancer of overlapping lesion of major salivary glands and major salivary gland, unspecified (C08.8–C08.9) |
| Melanoma of the skin | melanoma of the skin (C43) melanoma of the lip (C43.0) melanoma of the eyelid, including canthus (C43.1) melanoma of the ear and external auricular canal (C43.2) melanoma of other and unspecified parts of face (C43.3) melanoma of the scalp and neck (C43.4) melanoma of the trunk (C43.5) melanoma of the upper limb, including shoulder (C43.6) melanoma of the lower limb, including hip (C43.7) overlapping melanoma of the skin and melanoma of the skin, unspecified (C43.8–C43.9) |
| Mesothelioma | mesothelioma (C45) mesothelioma of the pleura (C45.0) mesothelioma of the peritoneum (C45.1) mesothelioma of the pericardium (C45.2) mesothelioma of other sites (C45.7) mesothelioma, unspecified (C45.9) |
| Mouth cancer | mouth cancer (C03–C06) cancer of the gum (C03) cancer of the upper gum (C03.0) cancer of the lower gum (C03.1) cancer of the gum, unspecified (C03.9) cancer of the floor of mouth (C04) cancer of the anterior floor of mouth (C04.0) cancer of the lateral floor of mouth (C04.1) cancer of overlapping lesion of floor of mouth and floor of mouth, unspecified (C04.8–C04.9) cancer of the palate (C05) cancer of the hard palate (C05.0) cancer of the soft palate (C05.1) cancer of the uvula (C05.2) cancer of overlapping lesion of palate and palate, unspecified (C05.8–C05.9) cancer of the other and unspecified parts of mouth (C06) cancer of the cheek mucosa (C06.0) cancer of the vestibule of mouth (C06.1) cancer of the retromolar area (C06.2) cancer of overlapping lesion of other and unspecified parts of mouth and mouth, unspecified (C06.8–C06.9) |
| Nasal cavity and middle ear cancer | nasal cavity and middle ear cancer (C30) cancer of the nasal cavity (C30.0) cancer of the middle ear (C30.1) |
| Nasopharyngeal cancer | nasopharyngeal cancer (C11) cancer of the superior wall of nasopharynx (C11.0) cancer of the posterior wall of nasopharynx (C11.1) cancer of the lateral wall of nasopharynx (C11.2) cancer of the anterior wall of nasopharynx (C11.3) cancer of overlapping lesion of nasopharynx and nasopharynx, unspecified (C11.8–C11.9) |
| Non-melanoma skin cancer (rare types) | non-melanoma skin cancer (rare types) (C44) non-melanoma skin cancer (rare types) of the lip (C44.0) non-melanoma skin cancer (rare types) of the eyelid, including canthus (C44.1) non-melanoma skin cancer (rare types) of the ear and external auricular canal (C44.2) non-melanoma skin cancer (rare types) of other and unspecified parts of face (C44.3) non-melanoma skin cancer (rare types) of the scalp and neck (C44.4) non-melanoma skin cancer (rare types) of the trunk (C44.5) non-melanoma skin cancer (rare types) of the upper limb, including shoulder (C44.6) non-melanoma skin cancer (rare types) of the lower limb, including hip (C44.7) overlapping lesion of non-melanoma skin cancer and non-melanoma skin cancer, unspecified (C44.8–C44.9) (rare types) |
| Oesophageal cancer | oesophageal cancer (C15) cancer of the cervical part of oesophagus (C15.0) cancer of the thoracic part of oesophagus (C15.1) cancer of the abdominal part of oesophagus (C15.2) cancer of the upper third of oesophagus (C15.3) cancer of the middle third of oesophagus (C15.4) cancer of the lower third of oesophagus (C15.5) cancer of overlapping lesion of oesophagus and oesophagus, unspecified (C15.8–C15.9) |
| Oral cancer | oral cancer (C00–C10) cancer of the lip (C00) cancer of the external upper lip (C00.0) cancer of the external lower lip (C00.1) cancer of the external lip, unspecified (C00.2) cancer of the upper lip, inner aspect (C00.3) cancer of the lower lip, inner aspect (C00.4) cancer of the lip, unspecified, inner aspect (C00.5) cancer of the commissure of lip (C00.6) cancer of overlapping lesion of lip and lip, unspecified (C00.8–C00.9) cancer of the base of tongue (C01) cancer of other and unspecified parts of tongue (C02) cancer of the dorsal surface of tongue (C02.0) cancer of other and unspecified parts of tongue (C02) cancer of the dorsal surface of tongue (C02.0) cancer of the border of tongue (C02.1) cancer of the ventral surface of tongue (C02.2) cancer of the anterior two-thirds of tongue, part unspecified (C02.3) cancer of the lingual tonsil (C02.4) cancer of overlapping lesion of tongue and tongue unspecified (C02.8–C02.9) cancer of the gum (C03) cancer of the upper gum (C03.0) cancer of the lower gum (C03.1) cancer of the gum, unspecified (C03.9) cancer of the floor of mouth (C04) cancer of the anterior floor of mouth (C04.0) cancer of the lateral floor of mouth (C04.1) cancer of overlapping lesion of floor of mouth and floor of mouth, unspecified (C04.8–C04.9) cancer of the palate (C05) cancer of the hard palate (C05.0) cancer of the soft palate (C05.1) cancer of the uvula (C05.2) cancer of overlapping lesion of palate and palate, unspecified (C05.8–C05.9) cancer of the other and unspecified parts of mouth (C06) cancer of the cheek mucosa (C06.0) cancer of the vestibule of mouth (C06.1) cancer of the retromolar area (C06.2) cancer of overlapping lesion of other and unspecified parts of mouth and mouth, unspecified (C06.8–C06.9) cancer of the parotid gland (C07) cancer of other and unspecified major salivary glands (C08) cancer of the submandibular gland (C08.0) cancer of the sublingual gland (C08.1) cancer of overlapping lesion of major salivary glands and major salivary gland, unspecified (C08.8–C08.9) cancer of the tonsils (C09) cancer of the tonsillar fossa (C09.0) cancer of the tonsillar pillar (anterior)(posterior) (C09.1) cancer of overlapping lesion of tonsil and tonsil, unspecified (C09.8–C09.9) cancer of the oropharynx (C10) cancer of the vallecula (C10.0) cancer of the anterior surface of epiglottis (C10.1) cancer of the lateral wall of oropharynx (C10.2) cancer of the posterior wall of oropharynx (C10.3) cancer of the branchial cleft (C10.4) cancer of overlapping lesion of oropharynx and oropharynx, unspecified (C10.8–C10.9) |
| Oropharyngeal cancer | oropharyngeal cancer (C09–C10) cancer of the tonsils (C09) cancer of the tonsillar fossa (C09.0) cancer of the tonsillar pillar (anterior)(posterior) (C09.1) cancer of overlapping lesion of tonsil and tonsil, unspecified (C09.8–C09.9) cancer of the oropharynx (C10) cancer of the vallecula (C10.0) cancer of the anterior surface of epiglottis (C10.1) cancer of the lateral wall of oropharynx (C10.2) cancer of the posterior wall of oropharynx (C10.3) cancer of the branchial cleft (C10.4) cancer of overlapping lesion of oropharynx and oropharynx, unspecified (C10.8–C10.9) |
| Other and ill-defined digestive organs (cancer of) | cancer of other and ill-defined digestive organs (C26) cancer of the intestinal tract, part unspecified (C26.0) cancer of the spleen (C26.1) cancer of overlapping lesion of digestive system and ill-defined sites within the digestive system (C26.8–C26.9) |
| Other and ill-defined sites (cancer of) | cancer of other and ill-defined sites (C76) cancer of the head, face and neck (C76.0) cancer of the thorax (C76.1) cancer of the abdomen (C76.2) cancer of the pelvis (C76.3) cancer of the upper limb (C76.4) cancer of the lower limb (C76.5) cancer of other ill-defined sites (C76.7) cancer of overlapping lesion of other and ill-defined sites (C76.8) |
| Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of) | cancer of other and ill-defined sites in the lip, oral cavity and pharynx (C14) cancer of the pharynx, unspecified (C14.0) cancer of overlapping lesion of lip, oral cavity and pharynx (C14.8) |
| Other and unspecified parts of biliary tract (cancer of) | cancer of other and unspecified parts of biliary tract (C24) cancer of the extrahepatic bile duct (C24.0) cancer of the ampulla of Vater (C24.1) cancer of overlapping lesion of biliary tract and biliary tract, unspecified (C24.8–C24.9) |
| Other and unspecified urinary organs (cancer of) | cancer of other and unspecified urinary organs (C68) cancer of the urethra (C68.0) cancer of the paraurethral gland (C68.1) cancer of overlapping lesion of urinary organs and urinary organ, unspecified (C68.8–C68.9) |
| Other central nervous system cancers | other central nervous system cancers (C70, C72, C75.1–C75.3) cancer of the meninges (C70) cancer of the cerebral meninges (C70.0) cancer of the spinal meninges (C70.1) cancer of the meninges, unspecified (C70.9) cancer of the spinal cord, cranial nerves and other parts of central nervous system (C72) cancer of the spinal cord (C72.0) cancer of the cauda equina (C72.1) cancer of the olfactory nerve (C72.2) cancer of the optic nerve (C72.3) cancer of the acoustic nerve (C72.4) cancer of other and unspecified cranial nerves (C72.5) cancer of overlapping lesion of brain and other parts of central nervous system and central nervous system, unspecified (C72.8–C72.9) cancer of the pituitary gland (C75.1) cancer of the pineal gland (C75.3) |
| Other endocrine glands (cancer of) | cancer of other endocrine glands (C74–C75, excluding C75.1–C75.3) cancer of the adrenal gland (C74) cancer of the cortex of adrenal gland (C74.0) cancer of the medulla of adrenal gland (C74.1) cancer of the adrenal gland, unspecified (C74.9) cancer of the parathyroid gland (C75.0) cancer of the carotid body (C75.4) cancer of the aortic body and other paraganglia (C75.5) cancer of the pluriglandular involvement, unspecified and endocrine gland, unspecified (C75.8–C75.9) |
| Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of) | cancer of other female genital organs excluding serous carcinomas of the fallopian tube (C57 excluding C57.0, C57.8 (with histologies 8441, 8460, 8461)) cancer of the fallopian tube (C57.0 excluding selected histologies) cancer of the broad ligament (C57.1) cancer of the parametrium (C57.3) cancer of the uterine adnexa, unspecified (C57.4) cancer of other specified female genital organs (C57.7) cancer of overlapping lesion of female genital organs and female genital organ, unspecified (C57.8–C57.9, excluding selected histologies in C57.8) |
| Other male genital organs (cancer of) | cancer of other male genital organs (C63) cancer of the epididymis (C63.0) cancer of the spermatic cord (C63.1) cancer of the scrotum (C63.2) cancer of other specified male genital organs (C63.7) cancer of overlapping lesion of male genital organs and male genital organ, unspecified (C63.8–C63.9) |
| Other thoracic and respiratory organs (cancer of) | cancer of other thoracic and respiratory organs (C37–C39) cancer of the thymus (C37) cancer of the heart, mediastinum and pleura (C38) cancer of the heart (C38.0) cancer of the anterior mediastinum (C38.1) cancer of the posterior mediastinum (C38.2) cancer of the mediastinum, part unspecified (C38.3) cancer of the pleura (C38.4) cancer of overlapping lesion of heart, mediastinum and pleura (C38.8) cancer of other and ill-defined sites in the respiratory system and intrathoracic organs (C39) cancer of the upper respiratory tract, part unspecified (C39.0) cancer of overlapping lesion of respiratory and intrathoracic organs and ill-defined sites within the respiratory system (C39.8–C39.9) |
| Ovarian cancer and serous carcinomas of the fallopian tube | ovarian cancer and serous carcinomas of the fallopian tube (C56 (all histologies) and C57.0, C57.8 (with histologies 8441, 8460, 8461)) cancer of the fallopian tube (C57.0 with selected histologies) cancer of overlapping lesion of female genital organs (C57.8 with selected histologies) |
| Pancreatic cancer | pancreatic cancer (C25) cancer of the head of pancreas (C25.0) cancer of the body of pancreas (C25.1) cancer of the tail of pancreas (C25.2) cancer of the pancreatic duct (C25.3) cancer of the endocrine pancreas (C25.4) cancer of other parts of pancreas (C25.7) cancer of overlapping lesion of pancreas and pancreas, part unspecified (C25.8–C25.9) |
| Penile cancer | penile cancer (C60) cancer of the prepuce (C60.0) cancer of the glans penis (C60.1) cancer of the body of penis (C60.2) cancer of overlapping lesion of penis and penis, unspecified (C60.8–C60.9) |
| Peripheral nerves and autonomic nervous system (cancer of) | cancer of peripheral nerves and autonomic nervous system (C47) cancer of peripheral nerves of head, face and neck (C47.0) cancer of peripheral nerves of upper limb, including shoulder (C47.1) cancer of peripheral nerves of lower limb, including hip (C47.2) cancer of peripheral nerves of thorax (C47.3) cancer of peripheral nerves of abdomen (C47.4) cancer of peripheral nerves of pelvis (C47.5) cancer of peripheral nerves of trunk, unspecified (C47.6) cancer of overlapping lesion of peripheral nerves and autonomic nervous system and peripheral nerves and autonomic nervous system, unspecified (C47.8–C47.9) |
| Retroperitoneal and peritoneal cancer | retroperitoneal and peritoneal cancer (C48) cancer of the retroperitoneum (C48.0) cancer of specified parts of peritoneum (C48.1) cancer of the peritoneum, unspecified (C48.2) cancer of overlapping lesion of retroperitoneum and peritoneum (C48.8) |
| Sinuses cancer | sinuses cancer (C31) cancer of the maxillary sinus (C31.0) cancer of the ethmoidal sinus (C31.1) cancer of the frontal sinus (C31.2) cancer of the sphenoidal sinus (C31.3) cancer of overlapping lesion of accessory sinuses and accessory sinus, unspecified (C31.8–C31.9) |
| Small intestine cancer | small intestine cancer (C17) cancer of the duodenum (C17.0) cancer of the jejunum (C17.1) cancer of the ileum (C17.2) cancer of Meckel's diverticulum (C17.3) cancer of overlapping lesion of small intestine and small intestine, unspecified (C17.8–C17.9) |
| Stomach cancer | stomach cancer (C16) cancer of the cardia (C16.0) cancer of the fundus of stomach (C16.1) cancer of the body of stomach (C16.2) cancer of the pyloric antrum (C16.3) cancer of the pylorus (C16.4) cancer of the lesser curvature of stomach, unspecified (C16.5) cancer of the greater curvature of stomach, unspecified (C16.6) cancer of overlapping lesion of stomach and stomach, unspecified (C16.8–C16.9) |
| Testicular cancer | testicular cancer (C62) cancer of the undescended testis (C62.0) cancer of the descended testis (C62.1) cancer of the testis, unspecified (C62.9) |
| Tongue cancer | tongue cancer (C01–C02) cancer of the base of tongue (C01) cancer of other and unspecified parts of tongue (C02) cancer of the dorsal surface of tongue (C02.0) cancer of the border of tongue (C02.1) cancer of the ventral surface of tongue (C02.2) cancer of the anterior two-thirds of tongue, part unspecified (C02.3) cancer of the lingual tonsil (C02.4) cancer of overlapping lesion of tongue and tongue unspecified (C02.8–C02.9) |
| Uterine cancer | uterine cancer (C54–C55) cancer of the corpus uteri (C54) cancer of the isthmus uteri (C54.0) cancer of the endometrium (C54.1) cancer of the myometrium (C54.2) cancer of the fundus uteri (C54.3) cancer of overlapping lesion of corpus uteri and corpus uteri, unspecified (C54.8–C54.9) cancer of the uterus, part unspecified (C55) |
| Vulvar cancer | vulvar cancer (C51) cancer of the labium majus (C51.0) cancer of the labium minus (C51.1) cancer of the clitoris (C51.2) cancer of overlapping lesion of vulva and vulva, unspecified (C51.8–C51.9) |
Head and neck cancer (excluding lip) is also provided within the report and is the same as head and neck cancer (including lip) with the exception that lip cancer and its subsites are excluded. While the report is described as cancer by subsite, for a few cancers, cancer by type would be a more accurate description.
Cancer list for blood cancers by histology
The following cancers have incidence data available within the blood cancer by histology reports. Histology describes the type of cells in which cancer originates. Survival data are available only where there are enough cases to derive a sufficiently reliable survival rate.
The cancer list is accompanied by prefixes to help identify the relationships between cancers. For example, B1 is the prefix ID for acute blood cancers, B1.01 is the prefix ID for acute lymphoblastic leukemia/lymphoma and is a type of acute blood cancer. The prefixes are provided for assistance only within this report and has nothing to do with the cancer outside of this specific assistance.
Blood cancer type (with prefix)
B1 Acute blood cancers
B1.01 Acute lymphoblastic leukaemia/lymphoma
B1.01.01 B lymphoblastic leukaemia/lymphoma
B1.01.01.01 B lymphoblastic leukaemia/lymphoma, NOS
B1.01.01.02 B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
B1.01.01.03 B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged
B1.01.01.04 B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
B1.01.01.05 B lymphoblastic leukaemia/lymphoma with hyperdiploidy
B1.01.01.06 B lymphoblastic leukaemia/lymphoma with hypodiploidy
B1.01.01.08 B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
B1.01.01.09 B lymphoblastic leukaemia/lymphoma, BCR-ABL1-like
B1.01.02 T lymphoblastic leukaemia/lymphoma
B1.01.03 Lymphoblastic leukaemia/lymphoma, NOS
B1.02 Acute myeloid leukaemia
B1.02.01 Acute myeloid leukaemia with recurrent genetic abnormalities
B1.02.01.01 Acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
B1.02.01.02 Acute myeloid leukaemia with inv(16)(p13.1;q22) or t(16;16)(p13.1;q22); CBFB-MYH11
B1.02.01.03 Acute promyelocytic leukaemia with PML-RARA
B1.02.01.04 Acute myeloid leukaemia with t(9;11)(p21.3;q23.3); KMT2A-MLLT3
B1.02.01.05 Acute myeloid leukaemia with t(6;9)(p23;q34.1); DEK-NUP214
B1.02.01.06 Acute myeloid leukaemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM
B1.02.01.07 Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1
B1.02.01.08 Acute myeloid leukaemia with BCR-ABL1
B1.02.01.09 Acute myeloid leukaemia with mutated NPM1
B1.02.01.10 Acute myeloid leukaemia with biallelic mutation of CEBPA
B1.02.01.11 Acute myeloid leukaemia with mutated RUNX1
B1.02.02 Acute myeloid leukaemia, defined by differentiation
B1.02.02.01 Acute myeloid leukaemia, minimal differentiation
B1.02.02.02 Acute myeloid leukaemia without maturation
B1.02.02.03 Acute myeloid leukaemia with maturation
B1.02.02.04 Acute basophilic leukaemia
B1.02.02.05 Acute myelomonocytic leukaemia
B1.02.02.06 Acute monocytic leukaemia
B1.02.02.07 Pure erythroid leukaemia
B1.02.02.08 Acute megakaryoblastic leukaemia
B1.02.02.09 Acute myeloid leukaemia with myelodysplasia-related changes
B1.02.02.10 Acute panmyelosis with myelofibrosis
B1.02.03 Acute myeloid leukaemia, secondary
B1.02.03.01 Therapy-related acute myeloid leukaemia
B1.02.03.02 Myeloid leukaemia associated with Down syndrome
B1.02.04 Acute myeloid leukaemia, other
B1.02.04.01 Myeloid sarcoma
B1.02.04.02 Blastic plasmacytoid dendritic cell neoplasm
B1.02.05 Acute myeloid leukaemia, NOS
B1.03 Acute leukaemias of ambiguous lineage
B1.03.01 Acute undifferentiated leukaemia
B1.03.02 Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1
B1.03.03 Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged
B1.03.04 Mixed phenotype acute leukaemia, B/myeloid, NOS
B1.03.05 Mixed phenotype acute leukaemia, T/myeloid, NOS
B1.03.06 Acute biphenotypic leukaemia
B2 Chronic/mature blood cancers
B2.01 Chronic myeloid neoplasms
B2.01.01 Myeloproliferative neoplasms
B2.01.01.01 Chronic myeloid leukaemia, BCR-ABL1 positive
B2.01.01.02 Chronic neutrophilic leukaemia
B2.01.01.03 Polycythaemia vera
B2.02.01.04 Lymphoplasmacytic lymphoma
B2.02.01.04.01 Waldenstrom macroglobulinaemia
B2.02.01.04.02 Lymphoplasmacytic lymphoma, NOS
B2.02.01.05 Plasma cell neoplasms
B2.02.01.05.01 Multiple myeloma
B2.02.01.05.02 Plasma cell leukaemia
B2.02.01.05.03 Solitary plasmacytoma of bone
B2.02.01.05.04 Extraosseous plasmacytoma
B2.02.01.05.05 Heavy chain disease
B2.02.01.06 Marginal zone lymphoma
B2.02.01.06.01 Splenic marginal zone lymphoma
B2.02.01.06.02 Extranodal marginal zone lymphoma (MALT lymphoma)
B2.02.01.06.03 Nodal marginal zone lymphoma
B2.02.01.07 Follicular lymphoma
B2.02.01.07.01 Follicular lymphoma, NOS
B2.02.01.07.02 Primary cutaneous follicle centre lymphoma
B2.02.01.08 Mantle cell lymphoma
B2.02.01.09 Diffuse large B-cell lymphoma (DLBCL)
B2.02.01.09.01 Diffuse large B-cell lymphoma, NOS
B2.02.01.09.02 Immunoblastic DLBCL
B2.02.01.09.03 HHV8 positive DLBCL, NOS
B2.02.01.10 T-cell/histiocyte-rich large B-cell lymphoma
B2.02.01.11 Lymphomatoid granulomatosis, grade 3
B2.02.01.12 Primary mediastinal large B-cell lymphoma
B2.02.01.13 Intravascular large B-cell lymphoma
B2.02.01.14 ALK positive large B-cell lymphoma
B2.02.01.15 Plasmablastic lymphoma
B2.02.01.16 Primary effusion lymphoma
B2.02.01.17 Burkitt lymphoma
B2.02.01.18 B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classic Hodgkin lymphoma
B2.02.01.19 Immunoproliferative disease, NOS
B2.02.02 Mature T- and NK-cell neoplasms
B2.02.02.01 T-cell prolymphocytic leukaemia
B2.02.02.02 T-cell large granular lymphocytic leukaemia
B2.02.02.03 Aggressive NK-cell leukaemia
B2.02.02.04 Systemic EBV positive T-cell lymphoma of childhood
B2.02.02.05 Adult T-cell leukaemia/lymphoma
B2.02.02.06 Extranodal NK/T-cell lymphoma, nasal type
B2.02.02.07 Intestinal T-cell lymphoma, NOS
B2.02.02.08 Hepatosplenic T-cell lymphoma
B2.02.02.09 Cutaneous T-cell lymphoma
B2.02.02.09.01 Mycosis fungoides
B2.02.02.09.02 Sezary syndrome
B2.02.02.09.03 Primary cutaneous anaplastic large cell lymphoma
B2.02.02.09.04 Subcutaneous panniculitis-like T-cell lymphoma
B2.02.02.09.05 Primary cutaneous gamma-delta T-cell lymphoma
B2.02.02.09.06 Cutaneous T-cell lymphoma, NOS
B2.02.02.10 Peripheral T-cell lymphoma, NOS
B2.02.02.11 Angioimmunoblastic T-cell lymphoma
B2.02.02.12 Anaplastic large cell lymphoma
B2.02.02.12.01 Anaplastic large cell lymphoma, ALK positive
B2.02.02.12.02 Anaplastic large cell lymphoma, ALK negative
B2.02.03 Hodgkin lymphoma
B2.02.03.01 Nodular lymphocyte predominant Hodgkin lymphoma
B2.02.03.02 Classic Hodgkin lymphoma
B2.02.03.02.01 Nodular sclerosis classic Hodgkin lymphoma
B2.02.03.02.02 Lymphocyte-rich classic Hodgkin lymphoma
B2.02.03.02.03 Mixed cellularity classic Hodgkin lymphoma
B2.02.03.02.04 Lymphocyte-depleted classic Hodgkin lymphoma
B2.02.03.03 Hodgkin lymphoma, NOS
B2.02.04 Unclassifiable mature lymphoid neoplasms
B2.03 Histiocytic and dendritic cell neoplasms
B2.03.01 Langerhans cell histiocytosis
B2.03.02 Langerhans cell sarcoma
B2.03.03 Erdheim-Chester disease
B2.03.04 Histiocytic sarcoma
B2.03.05 Interdigitating reticulum cell sarcoma
B2.03.06 Follicular dendritic cell sarcoma
B2.03.08 Malignant histiocytosis
B3 Unclassifiable blood cancers
B3.01 Lymphoma, NOS
B3.02 Non-Hodgkin lymphoma, NOS
B3.03 Leukaemia, NOS
B3.04 Lymphoid leukaemia, NOS
B3.05 Myeloid leukaemia, NOS
Cancer list for selected cancers by histology
The following cancers have incidence data available within the (selected) cancer by histology reports. Histology describes the type of cells or tissue in which cancer originates. Survival data are available only where there are enough cases to derive a sufficiently reliable survival rate.
The cancer list is accompanied by prefixes to help identify the relationships between cancers. For example, C1.01 is the prefix ID for carcinomas, C1.01.01 is the prefix ID for squamous cell carcinoma and is a type of carcinoma. The prefixes are provided for assistance only within this report and has nothing to do with the cancer outside of this specific assistance.
| Cancer | Cancer type (hy histology) |
|---|---|
| Brain cancer | B1.01 Gliomas, glioneuronal tumours, and neuronal tumours B1.01.01 Adult-type diffuse gliomas B1.01.01.01 Astrocytoma, IDH-mutant B1.01.01.01.01 Astrocytoma, IDH-mutant grade 2 & Astrocytoma, NOS B1.01.01.01.02 Astrocytoma, IDH-mutant, grade 3 B1.01.01.01.03 Astrocytoma, IDH-mutant, grade 4 B1.01.01.02 Oligodendroglioma, IDH-mutant and 1p/19q-codeleted B1.01.01.02.01 Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 2 & Oligodendroglioma NOS B1.01.01.02.02 Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3 B1.01.01.02.03 Oligodendroblastoma [obs] B1.01.01.03 Glioblastoma, IDH-wildtype B1.01.01.03.01 Glioblastoma, IDH-wildtype & Epithelioid glioblastoma & Glioblastoma, NOS B1.01.01.03.02 Giant cell glioblastoma B1.01.01.03.03 Gliosarcoma B1.01.01.04 Gliomatosis cerebri B1.01.01.05 Oligoastrocytoma B1.01.01.06 Protoplasmic astrocytoma [obs] B1.01.01.07 Gemistocytic astrocytoma B1.01.01.08 Fibrillary astrocytoma B1.01.02 Paediatric-type diffuse high-grade gliomas B1.01.02.01 Diffuse midline glioma, H3 K27-altered & Diffuse hemispheric glioma, H3 G34-mutant & Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype & Infant-type hemispheric glioma B1.01.03 Circumscribed astrocytic gliomas B1.01.03.01 Pilomyxoid astrocytoma B1.01.03.02 High-grade astrocytoma with piloid features B1.01.03.03 Pleomorphic xanthoastrocytoma B1.01.03.04 Astroblastoma, MN1-altered & Astroblastoma, NOS B1.01.04 Glioneuronal and neuronal tumours B1.01.04.01 Ganglioglioma, anaplastic B1.01.04.02 Ganglioneuroblastoma B1.01.04.03 Neuroepithelioma, NOS B1.01.05 Ependymal tumours B1.01.05.01 Supratentorial ependymoma, NOS & Posterior fossa ependymoma, NOS & Ependymoma, NOS B1.01.05.02 Supratentorial ependymoma, ZFTA fusion-positive & Supratentorial ependymoma, YAP1 fusion-positive & Posterior fossa group A (PFA) ependymoma & Posterior fossa group B (PFB) ependymoma B1.01.05.03 Ependymoma, anaplastic B1.01.05.04 Papillary ependymoma B1.01.06 Unclassifiable gliomas B1.01.06.01 Glioma, malignant, NOS B1.02 Choroid plexus tumours B1.02.01 Choroid plexus carcinoma B1.03 Embryonal tumours B1.03.01 Medulloblastomas B1.03.01.01 Medulloblastoma, SHH-activated and TP53-wildtype & Desmoplastic/nodular medulloblastoma & Medulloblastoma with extensive nodularity B1.03.01.02 Medulloblastoma, SHH-activated and TP53 mutant B1.03.01.03 Medulloblastoma, non-WNT/non-SHH B1.03.01.04 Classic meduloblastoma & Medulloblastoma, NOS B1.03.01.05 Large cell / anaplastic medulloblastoma B1.03.01.06 Medullomyoblastoma [obs] B1.03.02 Other embryonal tumours B1.03.02.01 Atypical teratoid/rhabdoid tumour B1.03.02.02 Embryonal tumour with multilayered rosettes B1.03.02.03 CNS neuroblastoma, FOXR2-activated & CNS tumour with BCOR internal tandem duplication & Neuroblastoma, NOS B1.03.02.04 CNS embryonal tumour, NEC/NOS B1.04 Germ cell tumours B1.04.01 Immature teratoma B1.04.02 Germinoma B1.04.03 Embryonal carcinoma B1.04.04 Mixed germ cell tumour B1.04.05 Dysgerminoma B1.05 Other cancers B1.05.01 Squamous cell carcinoma, NOS B1.05.02 Malignant melanoma, NOS |
| Breast cancer | B1.01 Carcinomas B1.01.01 Ductal carcinomas B1.01.01.01 Pleomorphic carcinoma B1.01.01.02 Lymphoepithelial carcinoma B1.01.01.03 Adenocarcinoma, NOS B1.01.01.04 Scirrhous adenocarcinoma [obs] B1.01.01.05 Superficial spreading adenocarcinoma B1.01.01.06 Basal cell carcinoma B1.01.01.07 Cribriform carcinoma, NOS B1.01.01.08 Tubular adenocarcinoma B1.01.01.09 Solid carcinoma, NOS B1.01.01.10 Adenocarcinoma with mixed subtypes B1.01.01.11 Oncocytic carcinoma B1.01.01.12 Clear cell adenocarcinoma, NOS B1.01.01.13 Lipid-rich carcinoma B1.01.01.14 Glycogen-rich carcinoma B1.01.01.15 Granular cell carcinoma B1.01.01.16 Mixed cell adenocarcinoma B1.01.01.17 Apocrine adenocarcinoma B1.01.01.18 Sebaceous carcinoma B1.01.01.19 Mucinous adenocarcinoma, NOS B1.01.01.20 Mucin-producing adenocarcinoma B1.01.01.21 Signet ring cell carcinoma B1.01.01.22 Infiltrating duct carcinoma, NOS B1.01.01.23 Comedocarcinoma, NOS B1.01.01.24 Invasive micropapillary carcinoma of breast B1.01.01.25 Cystic hypersecretory carcinoma [obs] B1.01.01.26 Medullary carcinoma, NOS B1.01.01.27 Medullary carcinoma with lymphoid stroma [obs] B1.01.01.28 Atypical medullary carcinoma B1.01.01.29 Duct carcinoma, desmoplastic type B1.01.01.30 Infiltrating ductular carcinoma B1.01.01.31 Infiltrating duct and lobular carcinoma B1.01.01.32 Infiltrating duct mixed with other types of carcinoma B1.01.01.33 Inflammatory carcinoma B1.01.01.34 Paget disease, mammary B1.01.01.35 Paget disease and infiltrating duct carcinoma of breast B1.01.01.36 Paget disease and intraductal carcinoma of breast B1.01.01.37 Adenocarcinoma with squamous metaplasia B1.01.01.38 Adenocarcinoma with cartilaginous and osseous metaplasia B1.01.01.39 Adenocarcinoma with spindle cell metaplasia B1.01.01.40 Adenocarcinoma with apocrine metaplasia B1.01.01.41 Adenocarcinoma with neuroendocrine differentiation B1.01.01.42 Metaplastic carcinomas B1.01.01.42.01 Spindle cell carcinoma, NOS B1.01.01.42.02 Pseudosarcomatous carcinoma B1.01.01.42.03 Carcinoma with osteoclast-like giant cells B1.01.01.42.04 Squamous cell carcinoma B1.01.01.42.05 Squamous cell carcinoma, keratinising, NOS B1.01.01.42.06 Squamous cell carcinoma, large cell, nonkeratinising, NOS B1.01.01.42.07 Squamous cell carcinoma, spindle cell B1.01.01.42.08 Adenosquamous carcinoma B1.01.01.42.09 Metaplastic carcinoma, NOS B1.01.01.42.10 Carcinosarcoma, NOS B1.01.02 Lobular carcinomas B1.01.02.01 Lobular carcinoma, pleomorphic B1.01.02.02 Lobular carcinoma, NOS B1.01.02.03 Infiltrating lobular mixed with other types of carcinoma B1.01.03 Papillary carcinomas B1.01.03.01 Papillary carcinoma, NOS B1.01.03.02 Papillary adenocarcinoma B1.01.03.03 Intraductal papillary adenocarcinoma with invasion B1.01.03.04 Encapsulated papillary carcinoma with invasion B1.01.03.05 Solid papillary carcinoma with invasion B1.01.04 Salivary gland-type carcinomas B1.01.04.01 Adenoid cystic carcinoma B1.01.04.02 Mucoepidermoid carcinoma B1.01.04.03 Secretory carcinoma B1.01.04.04 Acinar cell carcinoma B1.01.05 Neuroendocrine neoplasms B1.01.05.01 Neuroendocrine tumours B1.01.05.01.01 Neuroendocrine tumour, grade 1 and NOS B1.01.05.01.02 Neuroendocrine tumour, grade 2 B1.01.05.02 Neuroendocrine carcinomas B1.01.05.02.01 Large cell neuroendocrine carcinoma B1.01.05.02.02 Small cell carcinoma B1.01.05.02.03 Combined small cell carcinoma B1.01.05.02.04 Neuroendocrine carcinoma, NOS B1.01.06 Epithelial-myoepithelial carcinoma B1.01.06.01 Epithelial-myoepithelial carcinoma B1.01.06.02 Carcinoma ex pleomorphic adenoma B1.01.06.03 Myoepithelial carcinoma B1.01.06.04 Adenomyoepithelioma with carcinoma B1.01.07 Unclassifiable carcinomas B1.01.07.01 Carcinoma, NOS B1.01.07.02 Large cell carcinoma, NOS B1.01.07.03 Carcinoma, undifferentiated, NOS B1.01.07.04 Carcinoma, anaplastic, NOS B1.01.07.05 Non-small cell carcinoma B1.02 Sarcomas B1.02.01 Liposarcomas B1.02.01.01 Liposarcoma, NOS B1.02.01.02 Liposarcoma, well differentiated, NOS B1.02.01.03 Myxoid liposarcoma B1.02.01.04 Pleomorphic liposarcoma B1.02.02 Fibroblastic and myofibroblastic sarcomas B1.02.02.01 Fibrosarcoma, NOS B1.02.02.02 Myxofibrosarcoma B1.02.02.03 Solitary fibrous tumour, malignant B1.02.02.04 Myofibroblastic sarcoma B1.02.03 Vascular sarcomas B1.02.03.01 Haemangiosarcoma B1.02.03.02 Lymphangiosarcoma B1.02.04 Smooth muscle sarcomas B1.02.04.01 Leiomyosarcoma, NOS B1.02.04.02 Angiomyosarcoma B1.02.04.03 Myosarcoma B1.02.05 Skeletal muscle sarcomas B1.02.05.01 Rhabdomyosarcoma, NOS B1.02.05.02 Spindle cell rhabdomyosarcoma B1.02.06 Stromal sarcomas B1.02.06.01 Stromal sarcoma, NOS B1.02.07 Bone and cartilage type sarcomas B1.02.07.01 Extraskeletal osteosarcoma B1.02.08 Malignant peripheral nerve sheath tumours B1.02.08.01 Malignant peripheral nerve sheath tumour, NOS B1.02.08.02 Granular cell tumour, malignant B1.02.09 Undifferentiated small round cell sarcomas of soft tissue B1.02.09.01 Ewing sarcoma B1.02.10 Sarcomas of uncertain differentiation B1.02.10.01 Undifferentiated pleomorphic sarcoma B1.02.10.02 Synovial sarcoma, NOS B1.02.11 Unclassifiable saromas B1.02.11.01 Sarcoma, NOS B1.02.11.02 Spindle cell sarcoma B1.02.11.03 Giant cell sarcoma B1.02.11.04 Undifferentiated sarcoma B1.03 Other breast cancers B1.03.01 Mixed tumour, malignant, NOS B1.03.02 Phyllodes tumour, malignant B1.04 Unclassifiable breast cancers B1.04.01 Neoplasm, malignant B1.04.02 Tumour cells, malignant B1.04.03 Malignant tumour, spindle cell type |
| Cervical cancer | C1.01 Epithelial cancers (carcinomas) C1.01.01 Squamous cell carcinomas C1.01.01.01 Verrucous carcinoma, NOS C1.01.01.02 Papillary squamous cell carcinoma, NOS C1.01.01.03 Squamous cell carcinoma, NOS C1.01.01.04 Squamous cell carcinoma, keratinising, NOS C1.01.01.05 Squamous cell carcinoma, large cell, nonkeratinising, NOS C1.01.01.06 Squamous cell carcinoma, nonkeratinising, NOS C1.01.01.07 Squamous cell carcinoma, spindle cell C1.01.01.08 Squamous cell carcinoma, adenoid C1.01.01.09 Squamous cell carcinoma, microinvasive C1.01.01.10 Lymphoepithelial carcinoma C1.01.01.11 Basaloid squamous cell carcinoma C1.01.01.12 Squamous cell carcinoma, clear cell type C1.01.01.13 Squamous cell carcinoma, HPV-associated C1.01.01.14 Squamous cell carcinoma, HPV-independent C1.01.01.15 Basaloid carcinoma C1.01.02 Adenocarcinomas C1.01.02.01 Adenocarcinoma, NOS C1.01.02.02 Scirrhous adenocarcinoma [obs] C1.01.02.03 Superficial spreading adenocarcinoma C1.01.02.04 Adenocarcinoma, intestinal type C1.01.02.05 Adenoid cystic carcinoma C1.01.02.06 Solid carcinoma, NOS C1.01.02.07 Adenocarcinoma with mixed subtypes C1.01.02.08 Papillary adenocarcinoma, NOS C1.01.02.09 Villous adenocarcinoma C1.01.02.10 Adenocarcinoma in tubulovillous adenoma C1.01.02.11 Adenocarcinoma, HPV-independent, clear cell type C1.01.02.12 Clear cell adenocarcinofibroma C1.01.02.13 Mixed cell adenocarcinoma C1.01.02.14 Endometrioid adenocarcinoma, NOS C1.01.02.15 Adenocarcinoma, endocervical type, NOS C1.01.02.16 Serous carcinoma, NOS C1.01.02.17 Low grade serous carcinoma C1.01.02.18 High grade serous carcinoma C1.01.02.19 Seromucinous carcinoma C1.01.02.20 Mucinous adenocarcinoma, NOS C1.01.02.21 Mucin-producing adenocarcinoma C1.01.02.22 Adenocarcinoma, HPV-independent, gastric type C1.01.02.23 Signet ring cell carcinoma C1.01.02.24 Adenocarcinoma with squamous metaplasia C1.01.02.25 Adenocarcinoma with neuroendocrine differentiation C1.01.02.26 Adenocarcinoma, HPV-independent, mesonephric type C1.01.03 Neuroendocrine neoplasms C1.01.03.01 Neuroendocrine tumours C1.01.03.01.01 Neuroendocrine tumour, grade 1 and NOS C1.01.03.01.02 Neuroendocrine tumour, grade 2 C1.01.03.02 Neuroendocrine carcinomas C1.01.03.02.01 Large cell neuroendocrine carcinoma C1.01.03.02.02 Small cell carcinoma, NOS C1.01.03.02.03 Combined small cell carcinoma C1.01.03.02.04 Mixed adenoneuroendocrine carcinoma C1.01.03.02.05 Neuroendocrine carcinoma, NOS C1.01.04 Other carcinomas C1.01.04.01 Giant cell and spindle cell carcinoma C1.01.04.02 Pseudosarcomatous carcinoma C1.01.04.03 Adenoid basal carcinoma C1.01.04.04 Mucoepidermoid carcinoma C1.01.04.05 Adenosquamous carcinoma C1.01.05 Unclassifiable carcinomas C1.01.05.01 Carcinoma, NOS C1.01.05.02 Large cell carcinoma, NOS C1.01.05.03 Glassy cell carcinoma C1.01.05.04 Carcinoma, undifferentiated, NOS C1.01.05.05 Carcinoma, anaplastic, NOS C1.01.05.06 Pleomorphic carcinoma C1.01.05.07 Papillary carcinoma, NOS C1.02 Mesenchymal cancers (sarcomas) C1.02.01 Vascular sarcomas C1.02.01.01 Epithelioid haemangioendothelioma, NOS C1.02.02 Smooth muscle sarcomas C1.02.02.01 Leiomyosarcoma, NOS C1.02.02.02 Epithelioid leiomyosarcoma C1.02.02.03 Myxoid leiomyosarcoma C1.02.03 Skeletal muscle sarcomas C1.02.03.01 Rhabdomyosarcoma, NOS C1.02.03.02 Embryonal rhabdomyosarcoma, NOS C1.02.04 Stromal sarcomas C1.02.04.01 Stromal sarcoma, NOS C1.02.05 Malignant peripheral nerve sheath tumours C1.02.05.01 Malignant peripheral nerve sheath tumour, NOS C1.02.06 Sarcomas of uncertain differentiation C1.02.06.01 Alveolar soft part sarcoma C1.02.07 Unclassifiable sarcomas C1.02.07.01 Sarcoma, NOS C1.02.07.02 Spindle cell sarcoma C1.02.07.03 Undifferentiated sarcoma C1.03 Mixed epithelial and mesenchymal cancers C1.03.01 Adenosarcoma C1.03.02 Mixed tumour, malignant, NOS C1.03.03 Mullerian mixed tumour C1.03.04 Mesodermal mixed tumour C1.03.05 Carcinosarcoma, NOS C1.04 Other cervical cancers C1.04.01 Melanomas C1.04.01.01 Malignant melanoma, NOS C1.04.01.02 Amelanotic melanoma C1.04.01.03 Mucosal lentiginous melanoma C1.04.01.04 Spindle cell melanoma, NOS C1.04.02 Trophoblastic tumour, epithelioid C1.05 Unclassifiable cervical cancers C1.05.01 Malignant tumour, NOS C1.05.02 Tumour cells, malignant C1.05.03 Malignant tumour, small cell type |
| Colorectal cancer | C1.01 Carcinomas C1.01.01 Squamous cell carcinomas C1.01.01.01 Verrucous carcinoma, NOS C1.01.01.02 Squamous cell carcinoma, NOS C1.01.01.03 Squamous cell carcinoma, keratinising, NOS C1.01.01.04 Squamous cell carcinoma, large cell, nonkeratinising, NOS C1.01.01.05 Squamous cell carcinoma, microinvasive C1.01.01.06 Lymphoepithelial carcinoma C1.01.01.07 Basaloid squamous cell carcinoma C1.01.01.08 Squamous cell carcinoma, HPV positive C1.01.01.09 Basaloid carcinoma C1.01.01.10 Cloacogenic carcinoma [obs] C1.01.02 Adenocarcinomas C1.01.02.01 Adenocarcinoma, NOS C1.01.02.02 Scirrhous adenocarcinoma [obs] C1.01.02.03 Superficial spreading adenocarcinoma C1.01.02.04 Adenocarcinoma, intestinal type C1.01.02.05 Carcinoma, diffuse type C1.01.02.06 Cribriform carcinoma, NOS C1.01.02.07 Adenocarcinoma in adenomatous polyp C1.01.02.08 Tubular adenocarcinoma C1.01.02.09 Serrated adenocarcinoma C1.01.02.10 Adenocarcinoma in adenomatous polyposis coli C1.01.02.11 Adenocarcinoma in multiple adenomatous polyps C1.01.02.12 Goblet cell adenocarcinoma C1.01.02.13 Adenocarcinoma with mixed subtypes C1.01.02.14 Papillary adenocarcinoma, NOS C1.01.02.15 Adenocarcinoma in villous adenoma C1.01.02.16 Adenoma-like adenocarcinoma C1.01.02.17 Adenocarcinoma in tubulovillous adenoma C1.01.02.18 Micropapillary adenocarcinoma C1.01.02.19 Clear cell adenocarcinoma, NOS C1.01.02.20 Mixed cell adenocarcinoma C1.01.02.21 Endometrioid adenocarcinoma, NOS C1.01.02.22 Cystadenocarcinoma, NOS [obs] C1.01.02.23 Mucinous cystadenocarcinoma, NOS C1.01.02.24 Mucinous adenocarcinoma C1.01.02.25 Mucin-producing adenocarcinoma C1.01.02.26 Signet ring cell carcinoma C1.01.02.27 Medullary adenocarcinoma C1.01.02.28 Acinar cell carcinoma C1.01.02.29 Adenosquamous carcinoma C1.01.02.30 Adenocarcinoma with apocrine metaplasia C1.01.02.31 Adenocarcinoma with neuroendocrine differentiation C1.01.02.32 Metaplastic carcinoma, NOS C1.01.02.33 Carcinoma, undifferentiated, NOS C1.01.02.34 Carcinoma with sarcomatoid component C1.01.03 Neuroendocrine neoplasms C1.01.03.01 Neuroendocrine tumours C1.01.03.01.01 Neuroendocrine tumour, grade 1 or NOS C1.01.03.01.02 Enterochromaffin cell carcinoid C1.01.03.01.03 Enterochromaffin-like cell tumour C1.01.03.01.04 Neuroendocrine tumour, grade 2 or grade 3 C1.01.03.02 Neuroendocrine carcinomas C1.01.03.02.01 Large cell neuroendocrine carcinoma C1.01.03.02.02 Small cell carcinoma, NOS C1.01.03.02.03 Small cell carcinoma, intermediate cell C1.01.03.02.04 Neuroendocrine carcinoma, NOS C1.01.03.03 Mixed neuroendocrine and non-neuroendocrine neoplasms C1.01.03.03.01 Combined small cell carcinoma C1.01.03.03.02 Mixed neuroendocrine non-neuroendocrine neoplasm C1.01.03.03.03 Mixed adenoneuroendocrine carcinoma C1.01.03.03.04 Adenocarcinoid tumour [obs] C1.01.04 Other carcinomas C1.01.04.01 Giant cell and spindle cell carcinoma C1.01.04.02 Giant cell carcinoma C1.01.04.03 Spindle cell carcinoma, NOS C1.01.04.04 Epithelial-myoepithelial carcinoma C1.01.05 Unclassifiable carcinomas C1.01.05.01 Carcinoma, NOS C1.01.05.02 Large cell carcinoma, NOS C1.01.05.03 Large cell carcinoma with rhabdoid phenotype C1.01.05.04 Carcinoma, anaplastic, NOS C1.01.05.05 Pleomorphic carcinoma C1.01.05.06 Non-small cell carcinoma C1.02 Sarcomas C1.02.01 Liposarcomas C1.02.01.01 Liposarcoma, NOS C1.02.01.02 Liposarcoma, well differentiated, NOS C1.02.01.03 Dedifferentiated liposarcoma C1.02.02 Fibroblastic and myofibroblastic sarcomas C1.02.02.01 Myxofibrosarcoma C1.02.02.02 Solitary fibrous tumour, malignant C1.02.02.03 Myofibroblastic sarcoma C1.02.03 Vascular sarcomas C1.02.03.01 Haemangiosarcoma C1.02.04 Smooth muscle sarcomas C1.02.04.01 Leiomyosarcoma, NOS C1.02.04.02 Epithelioid leiomyosarcoma C1.02.06 Stromal sarcomas C1.02.06.01 Gastrointestinal stromal tumour C1.02.07 Malignant peripheral nerve sheath tumours C1.02.07.01 Granular cell tumour, malignant C1.02.08 Sarcomas of uncertain differentiation C1.02.08.01 Synovial sarcomas C1.02.08.01.01 Synovial sarcoma, NOS C1.02.08.01.02 Synovial sarcoma, spindle cell C1.02.08.02 Desmoplastic small round cell tumour C1.02.08.03 Rhabdoid tumour, NOS C1.02.08.04 Perivascular epithelioid tumour, malignant C1.02.08.05 Undifferentiated sarcomas C1.02.08.05.01 Undifferentiated sarcoma C1.02.08.05.02 Spindle cell sarcoma, undifferentiated C1.02.08.05.03 Pleomorphic sarcoma, undifferentiated C1.02.08.05.04 Malignant fibrous histiocytoma [obs] C1.02.09 Undifferentiated small round cell sarcomas C1.02.09.01 Ewing sarcoma C1.02.10 Unclassifiable sarcomas C1.02.10.01 Sarcoma, NOS C1.03 Other cancers C1.03.01 Paraganglioma, NOS C1.03.02 Melanomas C1.03.02.01 Malignant melanoma, NOS C1.03.02.02 Nodular melanoma C1.03.02.03 Amelanotic melanoma C1.03.02.04 Mucosal lentiginous melanoma C1.03.02.05 Spindle cell melanoma, NOS C1.03.03 Carcinosarcoma, NOS C1.03.04 Germ cell and trophoblastic cancers C1.03.04.01 Yolk sac tumour, NOS C1.03.04.02 Choriocarcinoma, NOS C1.03.05 Ganglioneuroblastoma C1.04 Unclassifiable cancers C1.04.01 Neoplasm, malignant C1.04.02 Tumour cells, malignant C1.04.03 Malignant tumour, small cell type C1.04.04 Malignant tumour, giant cell type C1.04.05 Malignant tumour, spindle cell type |
| Kidney cancer | K1.01 Carcinomas K1.01.01 Adenocarcinomas K1.01.01.01 Adenocarcinoma, NOS K1.01.01.02 Tubular adenocarcinoma K1.01.01.03 Adenocarcinoma with mixed subtypes K1.01.01.04 Papillary adenocarcinoma K1.01.01.05 Adenocarcinoma in tubulovillous adenoma K1.01.01.06 Oncocytic carcinoma K1.01.01.07 Clear cell adenocarcinoma K1.01.01.08 Eosinophilic solid and cystic renal cell carcinoma & TFE3-rearranged renal cell carcinoma & TFEB-altered renal cell carcinoma & ELOC (formerly TCEB1)-mutated renal cell carcinoma & Fumarate hydratase-deficient renal cell carcinoma & Hereditary leiomy K1.01.01.09 Renal cell carcinoma, NOS K1.01.01.10 Clear cell adenocarcinofibroma K1.01.01.11 Tubulocystic renal cell carcinoma & Acquired cystic disease-associated renal cell carcinoma K1.01.01.12 Chromophobe renal cell carcinoma K1.01.01.13 Renal cell carcinoma, sarcomatoid K1.01.01.14 Collecting duct carcinoma K1.01.01.15 Granular cell carcinoma K1.01.01.16 Mixed cell adenocarcinoma K1.01.01.17 Mucinous tubular and spindle cell carcinoma K1.01.01.18 Mucin-producing adenocarcinoma K1.01.01.19 Medullary carcinoma, NOS K1.01.01.20 Adenosquamous carcinoma K1.01.01.21 Adenocarcinoma with neuroendocrine differentiation K1.01.02 Neuroendocrine neoplasms K1.01.02.01 Neuroendocrine tumours K1.01.02.01.01 Neuroendocrine tumour, grade 1 or NOS K1.01.02.02 Neuroendocrine carcinomas K1.01.02.02.01 Large cell neuroendocrine carcinoma K1.01.02.02.02 Small cell carcinoma K1.01.02.02.03 Neuroendocrine carcinoma, NOS K1.01.03 Other carcinomas K1.01.03.01 Giant cell carcinoma K1.01.03.02 Spindle cell carcinoma K1.01.03.03 Pseudosarcomatous carcinoma K1.01.03.04 Carcinosarcoma K1.01.04 Unclassifiable carcinomas K1.01.04.01 Carcinoma, NOS K1.01.04.02 Large cell carcinoma, NOS K1.01.04.03 Carcinoma, undifferentiated, NOS K1.01.04.04 Carcinoma, anaplastic, NOS K1.01.04.05 Pleomorphic carcinoma K1.02 Sarcomas K1.02.01 Liposarcomas K1.02.01.01 Angiomyolipoma, epithelioid, malignant K1.02.02 Fibroblastic and myofibroblastic sarcomas K1.02.02.01 Solitary fibrous tumour, malignant K1.02.03 Vascular sarcomas K1.02.03.01 Haemangiosarcoma K1.02.04 Smooth muscle sarcomas K1.02.04.01 Leiomyosarcoma, NOS K1.02.04.02 Angiomyosarcoma K1.02.04.03 Myxoid leiomyosarcoma K1.02.05 Skeletal muscle sarcomas K1.02.05.01 Rhabdomyosarcoma, NOS K1.02.05.02 Embryonal rhabdomyosarcoma, NOS K1.02.06 Bone and cartilage type sarcomas of soft tissue K1.02.06.01 Extraskeletal osteosarcoma K1.02.07 Sarcomas of uncertain differentiation K1.02.07.01 Synovial sarcomas K1.02.07.01.01 Synovial sarcoma, NOS K1.02.07.01.02 Synovial sarcoma, spindle cell K1.02.07.02 Rhabdoid tumour, NOS K1.02.07.03 Perivascular epithelioid tumour, malignant K1.02.07.04 Undifferentiated sarcomas K1.02.07.04.01 Undifferentiated sarcoma K1.02.07.04.02 Spindle cell sarcoma K1.02.07.04.03 Giant cell sarcoma K1.02.07.04.04 Malignant fibrous histiocytoma [obs] K1.02.08 Undifferentiated small round cell sarcomas K1.02.08.01 Ewing sarcoma K1.02.09 Other sarcomas K1.02.09.01 Clear cell sarcoma of kidney K1.02.10 Unclassifiable sarcomas K1.02.10.01 Sarcoma, NOS K1.03 Other cancers K1.03.01 Malignant cystic nephroma K1.03.02 Nephroblastoma K1.03.03 Germ cell cancers K1.03.03.01 Yolk sac tumour, NOS K1.03.03.02 Mixed germ cell tumour K1.03.03.03 Choriocarcinoma, NOS K1.03.04 Primitive neuroectodermal tumour, NOS K1.03.05 Neuroblastoma, NOS K1.04 Unclassifiable cancers K1.04.01 Malignant tumour, NOS K1.04.02 Tumour cells, malignant K1.04.03 Malignant tumour, giant cell type K1.04.04 Malignant tumout, spindle cell type K1.04.05 Malignant tumour, clear cell type |
| Liver cancer | L1.01 Carcinomas L1.01.01 Hepatocellular carcinomas L1.01.01.01 Hepatocellular carcinoma, NOS L1.01.01.02 Hepatocellular carcinoma, fibrolamellar L1.01.01.03 Hepatocellular carcinoma, scirrhous L1.01.01.04 Hepatocellular carcinoma, spindle cell variant L1.01.01.05 Hepatocellular carcinoma, clear cell type L1.01.01.06 Hepatocellular carcinoma, pleomorphic type L1.01.02 Cholangiocarcinomas L1.01.02.01 Cholangiocarcinoma L1.01.02.02 Bile duct cystadenocarcinoma L1.01.02.03 Perihilar cholangiocarcinoma L1.01.03 Combined hepatocellular carcinoma and cholangiocarcinoma L1.01.04 Other and unspecified adenocarcinomas L1.01.04.01 Adenocarcinoma, NOS L1.01.04.02 Scirrhous adenocarcinoma [obs] L1.01.04.03 Adenocarcinoma with mixed subtypes L1.01.04.04 Papillary adenocarcinoma, NOS L1.01.04.05 Clear cell adenocarcinoma, NOS L1.01.04.06 Cystadenocarcinoma, NOS [obs] L1.01.04.07 Papillary cystadenocarcinoma, NOS [obs] L1.01.04.08 Mucinous cystadenocarcinoma, NOS L1.01.04.09 Mucinous adenocarcinoma, NOS L1.01.04.10 Mucin-producing adenocarcinoma L1.01.04.11 Signet ring cell carcinoma L1.01.04.12 Infiltrating duct carcinoma, NOS L1.01.04.13 Intraductal papillary adenocarcinoma with invasion L1.01.04.14 Acinar cell carcinoma L1.01.04.15 Adenosquamous carcinoma L1.01.04.16 Adenocarcinoma with neuroendocrine differentiation L1.01.05 Neuroendocrine neoplasms L1.01.05.01 Neuroendocrine tumours L1.01.05.01.01 Neuroendocrine tumour, grade 1 or NOS L1.01.05.01.02 Neuroendocrine tumour, grade 2 or grade 3 L1.01.05.02 Neuroendocrine carcinomas L1.01.05.02.01 Large cell neuroendocrine carcinoma L1.01.05.02.02 Small cell carcinoma L1.01.05.02.03 Neuroendocrine carcinoma, NOS L1.01.05.03 Mixed neuroendocrine and non-neuroendocrine neoplasms L1.01.05.03.01 Mixed neuroendocrine and non-neuroendocrine neoplasm L1.01.06 Other carcinomas L1.01.06.01 Giant cell carcinoma L1.01.06.02 Spindle cell carcinoma, NOS L1.01.06.03 Pseudosarcomatous carcinoma L1.01.06.04 Carcinosarcoma L1.01.07 Unclassifiable carcinomas L1.01.07.01 Carcinoma, NOS L1.01.07.02 Large cell carcinoma, NOS L1.01.07.03 Carcinoma, undifferentiated, NOS L1.01.07.04 Carcinoma, anaplastic, NOS L1.02 Sarcomas L1.02.01 Liposarcomas L1.02.01.01 Liposarcoma, NOS L1.02.02 Fibroblastic and myofibroblastic sarcomas L1.02.02.01 Solitary fibrous tumour, malignant L1.02.02.02 Myofibroblastic sarcoma L1.02.02.03 Myxosarcoma L1.02.03 Vascular sarcomas L1.02.03.01 Haemangiosarcoma L1.02.03.02 Haemangioendothelioma, malignant L1.02.03.03 Epithelioid haemangioendothelioma, NOS L1.02.04 Smooth muscle sarcomas L1.02.04.01 Leiomyosarcoma, NOS L1.02.04.02 Angiomyosarcoma L1.02.05 Skeletal muscle sarcomas L1.02.05.01 Rhabdomyosarcoma, NOS L1.02.05.02 Embryonal rhabdomyosarcoma, NOS L1.02.06 Sarcomas of uncertain differentiation L1.02.06.01 Perivascular epithelioid tumour, malignant L1.02.06.02 Desmoplastic small round cell tumour L1.02.06.03 Rhabdoid tumour, NOS L1.02.06.04 Undifferentiated sarcomas L1.02.06.04.02 Pleomorphic sarcoma, undifferentiated L1.02.06.04.03 Undifferentiated sarcoma L1.02.06.04.04 Malignant fibrous histiocytoma [obs] L1.02.06.04.05 Embryonal sarcoma L1.02.07 Unclassifiable sarcomas L1.02.07.01 Sarcoma, NOS L1.03 Other cancers L1.03.01 Hepatoblastoma, NOS L1.03.02 Yolk sac tumour, NOS L1.04 Unclassifiable cancers L1.04.01 Malignant tumour, NOS L1.04.02 Malignant tumour, giant cell type L1.04.03 Malignant tumour, spindle cell type |
| Lung cancer | L1.01 Carcinomas L1.01.01 Adenocarcinomas L1.01.01.01 Invasive non-mucinous adenocarcinoma or Adenocarcinoma, NOS L1.01.01.02 Scirrhous adenocarcinoma [obs] L1.01.01.03 Superficial spreading adenocarcinoma L1.01.01.04 Enteric-type adenocarcinoma L1.01.01.05 Cribriform carcinoma, NOS L1.01.01.06 Tubular adenocarcinoma L1.01.01.07 Solid adenocarcinoma, NOS L1.01.01.08 Lepidic adenocarcinoma L1.01.01.09 Alveolar adenocarcinoma [obs] L1.01.01.10 Bronchiolo-alveolar carcinoma, non-mucinous [obs] L1.01.01.11 Invasive mucinous adenocarcinoma L1.01.01.12 Mixed invasive mucinous and non-mucinous adenocarcinoma L1.01.01.13 Adenocarcinoma with mixed subtypes L1.01.01.14 Minimally invasive adenocarcinoma, non-mucinous L1.01.01.15 Minimally invasive adenocarcinoma, mucinous L1.01.01.16 Papillary adenocarcinoma, NOS L1.01.01.17 Micropapillary adenocarcinoma, NOS L1.01.01.18 Oxyphilic adenocarcinoma L1.01.01.19 Mixed cell adenocarcinoma L1.01.01.20 Fetal adenocarcinoma L1.01.01.21 Sebaceous carcinoma L1.01.01.22 Mucinous cystadenocarcinoma, NOS L1.01.01.23 Colloid adenocarcinoma L1.01.01.24 Mucin-producing adenocarcinoma L1.01.01.25 Signet ring cell carcinoma L1.01.01.26 Acinar cell carcinoma L1.01.01.27 Acinar cell cystadenocarcinoma L1.01.01.28 Adenocarcinoma with squamous metaplasia L1.01.01.29 Adenocarcinoma with spindle cell metaplasia L1.01.01.30 Adenocarcinoma with neuroendocrine differentiation L1.01.01.31 Hepatoid adenocarcinoma L1.01.02 Squamous cell carcinomas L1.01.02.01 Verrucous carcinoma, NOS L1.01.02.02 Papillary squamous cell carcinoma L1.01.02.03 Squamous cell carcinoma, NOS L1.01.02.04 Squamous cell carcinoma, keratinising, NOS L1.01.02.05 Squamous cell carcinoma, large cell, nonkeratinising, NOS L1.01.02.06 Squamous cell carcinoma, small cell, nonkeratinising L1.01.02.07 Squamous cell carcinoma, spindle cell L1.01.02.08 Squamous cell carcinoma, adenoid L1.01.02.09 Squamous cell carcinoma, microinvasive L1.01.02.10 Lymphoepithelial carcinoma L1.01.02.11 Basaloid squamous cell carcinoma L1.01.02.12 Squamous cell carcinoma, clear cell type L1.01.02.13 Squamous cell carcinoma, HPV-associated L1.01.03 Large cell carcinoma, NOS L1.01.04 Adenosquamous carcinoma L1.01.05 Sarcomatoid carcinomas L1.01.05.01 Pleomorphic carcinoma L1.01.05.02 Giant cell and spindle cell carcinoma L1.01.05.03 Giant cell carcinoma L1.01.05.04 Spindle cell carcinoma, NOS L1.01.05.05 Pseudosarcomatous carcinoma L1.01.05.06 Metaplastic carcinoma L1.01.05.07 Pulmonary blastoma L1.01.05.08 Carcinosarcoma L1.01.06 Salivary gland-type carcinomas L1.01.06.01 Adenoid cystic carcinoma L1.01.06.02 Hyalinising clear cell carcinoma L1.01.06.03 Mucoepidermoid carcinoma L1.01.06.04 Epithelial-myoepithelial carcinoma L1.01.06.05 Myoepithelial carcinoma L1.01.07 Neuroendocrine neoplasms L1.01.07.01 Neuroendocrine tumours L1.01.07.01.01 Neuroendocrine tumour, grade 1 or NOS L1.01.07.01.02 Neuroendocrine tumour, grade 2 or 3 L1.01.07.01.03 Enterochromaffin cell carcinoid L1.01.07.02 Neuroendocrine carcinomas L1.01.07.02.01 Large cell neuroendocrine carcinoma L1.01.07.02.02 Small cell carcinoma L1.01.07.02.03 Oat cell carcinoma [obs] L1.01.07.02.04 Small cell carcinoma, fusiform cell L1.01.07.02.05 Small cell carcinoma, intermediate cell [obs] L1.01.07.02.06 Neuroendocrine carcinoma, NOS L1.01.07.03 Mixed neuroendocrine and non-neuroendocrine neoplasms L1.01.07.03.01 Combined small cell carcinoma L1.01.07.03.02 Mixed adenoneuroendocrine carcinoma L1.01.07.03.03 Adenocarcinoid tumour [obs] L1.01.08 Other carcinomas L1.01.08.01 NUT carcinomas L1.01.08.02 Thoracic SMARCA4-deficient undifferentiated tumour L1.01.08.03 Basal cell carcinoma L1.01.08.04 Basaloid carcinoma L1.01.09 Unclassifiable carcinomas L1.01.09.01 Carcinoma, NOS L1.01.09.02 Large cell carcinoma with rhabdoid phenotype L1.01.09.03 Carcinoma, undifferentiated, NOS L1.01.09.04 Carcinoma, anaplastic, NOS L1.01.09.05 Non-small cell carcinoma L1.01.09.06 Papillary carcinoma, NOS L1.02 Sarcomas L1.02.01 Liposarcomas L1.02.01.01 Liposarcoma, NOS L1.02.02 Fibroblastic and myofibroblastic sarcomas L1.02.02.01 Fibrosarcoma, NOS L1.02.02.02 Myxofibrosarcoma L1.02.02.03 Solitary fibrous tumour, malignant L1.02.02.04 Myofibroblastic sarcoma L1.02.02.05 Myxosarcoma L1.02.03 Vascular sarcomas L1.02.03.01 Haemangiosarcoma L1.02.03.02 Haemangioendothelioma, malignant L1.02.03.03 Epithelioid haemangioendothelioma L1.02.04 Pericytic (perivascular) sarcomas L1.02.04.01 Glomus tumour, malignant L1.02.05 Smooth muscle sarcomas L1.02.05.01 Leiomyosarcoma, NOS L1.02.05.02 Epithelioid leiomyosarcoma L1.02.06 Bone and cartilage type sarcomas L1.02.06.01 Osteosarcoma, NOS L1.02.06.02 Chondrosarcoma, NOS L1.02.06.03 Mesenchymal chondrosarcoma L1.02.07 Malignant peripheral nerve sheath tumours L1.02.07.01 Malignant peripheral nerve sheath tumour, NOS L1.02.07.02 Neurilemoma, malignant [obs] L1.02.08 Sarcomas of uncertain differentiation L1.02.08.01 Spindle cell sarcoma L1.02.08.02 Giant cell sarcoma L1.02.08.03 Small cell sarcoma L1.02.08.04 Epithelioid sarcoma, NOS L1.02.08.05 Undifferentiated sarcoma L1.02.08.06 Malignant fibrous histiocytoma [obs] L1.02.08.08 Synovial sarcomas L1.02.08.08.01 Synovial sarcoma, NOS L1.02.08.08.02 Synovial sarcoma, spindle cell L1.02.08.08.03 Synovial sarcoma, biphasic L1.02.09 Undifferentiated small round cell sarcoma L1.02.09.01 Ewing sarcoma L1.02.10 Other sarcomas L1.02.10.01 Pleuropulmonary blastoma L1.02.11 Unclassifiable sarcomas L1.02.11.01 Sarcoma, NOS L1.03 Other cancers L1.03.01 Paraganglioma, NOS L1.03.02 Malignant melanoma, NOS L1.03.03 Germ cell tumours L1.03.03.01 Germ cell tumour, nonseminomatous L1.03.03.02 Teratoma with malignant transformation L1.04 Unclassifiable cancers L1.04.01 Malignant tumour, NOS L1.04.02 Tumour cells, malignant L1.04.03 Malignant tumour, small cell type L1.04.04 Malignant tumour, giant cell type L1.04.05 Malignant tumour, spindle cell type L1.04.06 Malignant tumour, clear cell type |
| Melanoma of the skin | S1.01 Malignant melanoma, NOS S1.02 Nodular melanoma S1.03 Balloon cell melanoma S1.04 Malignant melanoma, regressing S1.05 Amelanotic melanoma S1.06 Malignant melanoma in junctional naevus S1.07 Lentigo maligna melanoma S1.08 Low cumulative sun damage melanoma S1.09 Acral melanoma S1.10 Desmopastic melanoma S1.11 Malignant melanoma arising in giant congenital naevus S1.12 Malignant Spitz tumour S1.13 Epithelioid cell melanoma S1.14 Spindle cell melanoma, NOS S1.15 Spindle cell melanoma, type B S1.16 Blue naevus, malignant [obs] |
| Mesothelioma | M1.01 Mesothelioma, all histological types M1.01.01 Mesothelioma of pleura and pericardium M1.01.02 Mesothelioma of peritoneum and tunica vaginalis M1.01.03 Mesothelioma of unknown primary site M1.02 Epithelioid mesothelioma M1.02.01 Epithelioid mesothelioma of pleura and pericardium M1.02.02 Epithelioid mesothelioma of peritoneum and tunica vaginalis M1.02.03 Epithelioid mesothelioma of unknown primary site M1.03 Sarcomatoid mesothelioma M1.03.01 Sarcomatoid mesothelioma of pleura and pericardium M1.03.02 Sarcomatoid mesothelioma of peritoneum and tunica vaginalis M1.04 Biphasic mesothelioma M1.04.01 Biphasic mesothelioma of pleura and pericardium M1.04.02 Biphasic mesothelioma of peritoneum and tunica vaginalis M1.05 Mesothelioma, NOS M1.05.01 Mesothelioma, NOS of pleura and pericardium M1.05.02 Mesothelioma, NOS of peritoneum and tunica vaginalis M1.05.03 Mesothelioma, NOS of unknown primary site |
| Pancreatic cancer | P1.01 Carcinomas P1.01.01 Adenocarcinomas P1.01.01.01 Adenocarcinoma, NOS P1.01.01.02 Scirrhous adenocarcinoma [obs] P1.01.01.03 Superficial spreading adenocarcinoma P1.01.01.04 Adenocarcinoma, intestinal type P1.01.01.05 Pancreatobiliary type carcinoma P1.01.01.06 Adenocarcinoma in adenomatous polyp P1.01.01.07 Tubular adenocarcinoma P1.01.01.08 Solid carcinoma, NOS P1.01.01.09 Goblet cell adenocarcinoma P1.01.01.10 Adenocarcinoma with mixed subtypes P1.01.01.11 Papillary adenocarcinoma, NOS P1.01.01.12 Adenocarcinoma in villous adenoma P1.01.01.13 Villous adenocarcinoma P1.01.01.14 Adenocarcinoma in tubulovillous adenoma P1.01.01.15 Micropapillary carcinoma, NOS P1.01.01.16 Oxyphillic adenocarcinoma P1.01.01.17 Clear cell adenocarcinoma, NOS P1.01.01.18 Mixed cell adenocarcinoma P1.01.01.19 Mucoepidermoid carcinoma P1.01.01.20 Cystadenocarcinoma, NOS [obs] P1.01.01.21 Serous cystadenocarcinoma, NOS P1.01.01.22 Papillary cystadenocarcinoma, NOS [obs] P1.01.01.23 Solid pseudopapillary neoplasm of the pancreas P1.01.01.24 Intraductal papillary mucinous neoplasm with an associated invasive carcinoma P1.01.01.25 Intraductal oncocytic papillary neoplasm with an associated invasive carcinoma P1.01.01.26 Low grade serous carcinoma P1.01.01.27 Mucinous cystic neoplasm with an associated invasive carcinoma P1.01.01.28 Colloid carcinoma P1.01.01.29 Mucin-producing adenocarcinoma P1.01.01.30 Poorly cohesive carcinoma & Signet-ring cell carcinoma P1.01.01.31 Duct adenocarcinoma, NOS P1.01.01.32 Intraductal tubulopapillary neoplasm with an associated invasive carcinoma P1.01.01.33 Encapsulated papillary carcinoma with invasion P1.01.01.34 Cystic hypersecretory carcinoma [obs] P1.01.01.35 Infiltrating ductular carcinoma P1.01.01.36 Infiltrating duct mixed with other types of carcinoma P1.01.01.37 Acinar cell carcinoma P1.01.01.38 Adenosquamous carcinoma P1.01.01.39 Adenocarcinoma with squamous metaplasia P1.01.01.40 Adenocarcinoma with apocrine metaplasia P1.01.01.41 Adenocarcinoma with neuroendocrine differentiation P1.01.01.42 Metaplastic carcinoma, NOS P1.01.01.43 Hepatoid carcinoma P1.01.02 Squamous cell carcinomas P1.01.02.01 Squamous cell carcinoma, NOS P1.01.02.02 Squamous cell carcinoma, keratinising, NOS P1.01.03 Neuroendocrine neoplasms P1.01.03.01 Neuroendocrine tumours P1.01.03.01.01 Non-functioning neuroendocrine tumours P1.01.03.01.01.01 Pancreatic neuroendocrine tumour, non-functioning P1.01.03.01.01.02 Neuroendocrine tumour, grade 1 or NOS P1.01.03.01.01.03 Neuroendocrine tumour, grade 2 or 3 P1.01.03.01.02 Functioning neuroendocrine tumours P1.01.03.01.02.01 Insulinoma P1.01.03.01.02.02 Glucagonoma P1.01.03.01.02.03 Gastrinoma P1.01.03.01.02.04 VIPoma P1.01.03.01.02.05 Somatostatinoma P1.01.03.01.02.06 ACTH-producing tumour P1.01.03.01.02.07 Enterochromaffin cell carcinoid P1.01.03.02 Neuroendocrine carcinomas P1.01.03.02.01 Large cell neuroendocrine carcinoma P1.01.03.02.02 Small cell carcinoma P1.01.03.02.03 Neuroendocrine carcinoma, NOS P1.01.03.03 Mixed neuroendocrine and non-neuroendocrine neoplasms P1.01.03.03.01 Mixed neuroendocrine-non-neuroendocrine neoplasm P1.01.03.03.02 Mixed adenoneurocrine carcinoma P1.01.03.03.03 Adenocarcinoid tumour [obs] P1.01.04 Other carcinomas P1.01.04.01 Giant cell carcinoma P1.01.04.02 Spindle cell carcinoma, NOS P1.01.04.03 Pseudosarcomatous carcinoma P1.01.04.04 Undifferentiated carcinoma with osteoclast-like giant cells P1.01.04.05 Pancreatoblastoma P1.01.04.06 Carcinosarcoma P1.01.05 Unclassifiable carcinomas P1.01.05.01 Carcinoma, NOS P1.01.05.02 Large cell carcinoma, NOS P1.01.05.03 Carcinoma, undifferentiated, NOS P1.01.05.04 Carcinoma, anaplastic, NOS P1.01.05.05 Pleomorphic carcinoma P1.01.05.06 Non-small cell carcinoma P1.01.05.07 Papillary carcinoma, NOS P1.02 Sarcomas P1.02.01 Fibroblastic and myofibroblastic sarcomas P1.02.01.01 Myofibroblastic sarcomas P1.02.02 Vascular sarcomas P1.02.02.01 Epithelioid haemangioendothelioma, NOS P1.02.03 Smooth muscle sarcomas P1.02.03.01 Leiomyosarcoma, NOS P1.02.03.02 Epithelioid leiomyosarcoma P1.02.04 Stromal sarcomas P1.02.04.01 Gastrointestinal stromal tumour P1.02.05 Sarcomas of uncertain differentiation P1.02.05.01 Desmoplastic small round cell tumour P1.02.05.02 Undifferentiated sarcomas P1.02.05.02.01 Undifferentiated sarcoma P1.02.05.02.02 Spindle cell sarcoma, undifferentiated P1.02.05.02.03 Pleomorphic sarcoma, undifferentiated P1.02.05.02.04 Malignant fibrous histiocytoma [obs] P1.02.06 Undifferentiated small round cell sarcomas P1.02.06.01 Ewing sarcoma P1.02.07 Unclassifiable sarcomas P1.02.07.01 Sarcoma, NOS P1.03 Unclassifiable cancers P1.03.01 Malignant tumour, NOS P1.03.02 Tumour cells, malignant P1.03.03 Malignant tumour, giant cell type P1.03.04 Malignant tumour, spindle cell type |
| Prostate cancer | P1.01 Carcinomas P1.01.01 Adenocarcinomas P1.01.01.01 Acinar adenocarcinoma and adenocarcinoma, NOS P1.01.01.02 Adenocarcinoma, intestinal type P1.01.01.03 Cribriform carcinoma P1.01.01.04 Adenocarcinoma with mixed subtypes P1.01.01.05 Papillary adenocarcinoma, NOS P1.01.01.06 Clear cell adenocarcinoma, NOS P1.01.01.07 Mixed cell adenocarcinoma P1.01.01.08 Endometrioid adenocarcinoma, NOS P1.01.01.09 Mucinous adenocarcinoma P1.01.01.10 Mucin-producing adenocarcinoma P1.01.01.11 Signet ring cell carcinoma P1.01.01.12 Infiltrating duct carcinoma, NOS P1.01.01.13 Medullary carcinoma, NOS P1.01.01.14 Infiltrating duct mixed with other types of carcinoma P1.01.01.15 Mixed acinar-ductal carcinoma P1.01.01.16 Adenocarcinoma with squamous metaplasia P1.01.01.17 Acinar adenocarcinoma, sarcomatoid P1.01.01.18 Adenocarcinoma with neuroendocrine differentiation P1.01.01.19 Metaplastic carcinoma, NOS P1.01.01.20 Carcinosarcoma, NOS P1.01.02 Squamous carcinomas P1.01.02.01 Squamous cell carcinoma P1.01.02.01.01 Squamous cell carcinoma, NOS P1.01.02.01.02 Squamous cell carcinoma, keratinizing, NOS P1.01.02.02 Adenoid cystic (basal cell) carcinoma P1.01.02.03 Adenosquamous carcinoma P1.01.03 Urothelial carcinomas P1.01.03.01 Transitional cell carcinoma, NOS P1.01.03.02 Basaloid carcinoma P1.01.03.03 Papillary urothelial carcinoma P1.01.04 Neuroendocrine neoplasms P1.01.04.01 Neuroendocrine tumours P1.01.04.01.01 Neuroendocrine tumour, grade 1 and NOS P1.01.04.02 Neuroendocrine carcinomas P1.01.04.02.01 Large cell neuroendocrine carcinoma P1.01.04.02.02 Small cell carcinoma P1.01.04.02.03 Mixed small cell carcinoma P1.01.04.02.04 Neuroendocrine carcinoma, NOS P1.01.05 Other carcinomas P1.01.05.01 Giant cell and spindle cell carcinoma P1.01.05.02 Pseudosarcomatous carcinoma P1.01.06 Unclassifiable carcinomas P1.01.06.01 Carcinoma, NOS P1.01.06.02 Large cell carcinoma, NOS P1.01.06.03 Carcinoma, undifferentiated, NOS P1.01.06.04 Carcinoma, anaplastic, NOS P1.01.06.05 Pleomorphic carcinoma P1.01.06.06 Non-small cell carcinoma P1.01.06.07 Papillary carcinoma, NOS P1.02 Sarcomas P1.02.01 Fibroblastic and myofibroblastic sarcomas P1.02.01.01 Solitary fibrous tumour, malignant P1.02.02 Vascular sarcomas P1.02.02.01 Haemangiosarcoma P1.02.03 Smooth muscle sarcomas P1.02.03.01 Leiomyosarcoma, NOS P1.02.04 Skeletal muscle sarcomas P1.02.04.01 Rhabdomyosarcoma, NOS P1.02.04.02 Pleomorphic rhabdomyosarcoma, adult type P1.02.04.03 Embryonal rhabdomyosarcoma, NOS P1.02.04.04 Alveolar rhabdomyosarcoma P1.02.05 Stromal sarcomas P1.02.05.01 Stromal sarcoma, NOS P1.02.05.02 Gastrointestinal stromal tumour P1.02.06 Sarcomas of uncertain differentiation P1.02.06.01 Undifferentiated pleomorphic sarcoma P1.02.07 Unclassifiable sarcomas P1.02.07.01 Sarcoma, NOS P1.02.07.02 Spindle cell sarcoma P1.03 Other prostate cancers P1.03.01 Phyllodes tumour, malignant P1.04 Unclassifiable prostate cancers P1.04.01 Neoplasm, malignant P1.04.02 Malignant tumour, giant cell type P1.04.03 Malignant tumour, spindle cell type |